+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 52752

Chapter 52752 contains a list of PDF Full Texts available from EurekaMag.

Mondal, K.K.; Mani, C., 2010:
ERIC-PCR-generated genomic fingerprints and their relationship with pathogenic variability of Xanthomonas campestris pv. punicae, the incitant of bacterial blight of pomegranate

Boriani, E.; Mariani, A.; Baderna, D.; Moretti, C.; Lodi, M.; Benfenati, E., 2010:
ERICA: A multiparametric toxicological risk index for the assessment of environmental healthiness

Youngman, M.J.; Davis, K.E.; Etherington, G.; Marsh, J.W., 2007:
ERIDAS, a computer program for rapid calculation of internal doses from measurements of people in an emergency

Sun, W.; Li, Y.; Chen, L.; Chen, H.; You, F.; Zhou, X.; Zhou, Y.; Zhai, Z.; Chen, D.; Jiang, Z., 2009:
ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization

Polvino, K.Butler.; Antia, M.K.; Burnette, J.P., 2008:
ERISA as an obstacle to fair share legislation and other state initiatives to expand coverage to the uninsured and underinsured

Anonymous, 2011:
ERISA attorney fees--denial of claim for partial disability benefits--westinghouse factors--abuse of discretion--excessive fee request. Willcox v. Liberty Life Assur. Co., 368 Fed. Appx. 700, 2010 U.S. App. LEXIS 6248 (8th cir., 2010)

Allen, J.P.; Bales, R.A., 2012:
ERISA failures and the erosion of workers' rights: the urgent need to protect private & public workers' pension and benefits

Pierron, W.; Fronstin, P., 2008 :
ERISA pre-emption: implications for health reform and coverage

Slade, D.H., 2009:
ERISA preemption and the question of pharmacy benefit managers' fiduciary duty

Stiefel, J., 2008:
ERISA preemption of chapter 58: the future of the "pay or play" model of health care legislation

Nauta, R.Entigar., 2008:
ERISA preempts Maryland's Fair Share Health Care Fund Act: the chilling effect on state innovation in health cost-sharing with big business

Albala, I.C., 2011:
ERISA's effect on claims of injury due to denial of coverage

Bronsteen, J.; Maher, B.S.; Stris, P.K., 2008:
ERISA, agency costs, and the future of health care in the United States

Anonymous, 2009:
ERISA. Dealer could not show evidence of impairments from HIV

Black, L., 2008:
ERISA: A Close Look at Misguided Legislation

Szcześniak, Mł.Wojciech.; Kabza, Mł.; Pokrzywa, Rł.; Gudyś, A.; Makałowska, I., 2013:
ERISdb: a database of plant splice sites and splicing signals

Migliori, G.B.; Soriano, J.B.; Brusasco, V.; Dinh-Xuan, A.T., 2012:
ERJ peer reviewers: does this pillar of the Journal's quality need help?

Rak-Mardyla, A.; Gregoraszczuk, E.L., 2011:
ERK 1/2 and PI-3 kinase pathways as a potential mechanism of ghrelin action on cell proliferation and apoptosis in the porcine ovarian follicular cells

Wang, X.; Pesakhov, S.; Weng, A.; Kafka, M.; Gocek, E.; Nguyen, M.; Harrison, J.S.; Danilenko, M.; Studzinski, G.P., 2014:
ERK 5/MAPK pathway has a major role in 1α,25-(OH)2 vitamin D3-induced terminal differentiation of myeloid leukemia cells

Zhang, X.; Zhang, H.; Shao, H.; Xue, Q.; Yu, B., 2014:
ERK MAP kinase activation in spinal cord regulates phosphorylation of Cdk5 at serine 159 and contributes to peripheral inflammation induced pain/hypersensitivity

Marchant, D.; Sall, A.; Si, X.; Abraham, T.; Wu, W.; Luo, Z.; Petersen, T.; Hegele, R.G.; McManus, B.M., 2009:
ERK MAP kinase-activated Arf6 trafficking directs coxsackievirus type B3 into an unproductive compartment during virus host-cell entry

Luchetti, F.; Betti, M.; Canonico, B.; Arcangeletti, M.; Ferri, P.; Galli, F.; Papa, S., 2009:
ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells

Mracek, P.; Pagano, C.; Fröhlich, N.; Idda, M.Laura.; Cuesta, I.H.; Lopez-Olmeda, J.Fernando.; Sánchez-Vázquez, F.Javier.; Vallone, D.; Foulkes, N.S., 2013:
ERK Signaling Regulates Light-Induced Gene Expression via D-Box Enhancers in a Differential, Wavelength-Dependent Manner

Schmitt, J.M.; Abell, E.; Wagner, A.; Davare, M.A., 2010:
ERK activation and cell growth require CaM kinases in MCF-7 breast cancer cells

Hernández-Ortega, K.; Arias, C., 2013:
ERK activation and expression of neuronal cell cycle markers in the hippocampus after entorhinal cortex lesion

Hua, F.; Henstock, P.V.; Tang, B., 2011:
ERK activation by GM-CSF reduces effectiveness of p38 inhibitor on inhibiting TNFalpha release

Maher, P.; Dargusch, R.; Bodai, L.; Gerard, P.E.; Purcell, J.M.; Marsh, J.Lawrence., 2011:
ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease

Vara, H.; Onofri, F.; Benfenati, F.; Sassoè-Pognetto, M.; Giustetto, M., 2009:
ERK activation in axonal varicosities modulates presynaptic plasticity in the CA3 region of the hippocampus through synapsin I

Bertotto, Mía.Eugenia.; Maldonado, N.Martina.; Bignante, E.Anahi.; Gorosito, S.Vanesa.; Cambiasso, Mía.Julia.; Molina, Víctor.Alejandro.; Martijena, I.Delia., 2012:
ERK activation in the amygdala and hippocampus induced by fear conditioning in ethanol withdrawn rats: modulation by MK-801

Gomez-Sarosi, L.Alberto.; Strasberg-Rieber, M.; Rieber, M., 2009:
ERK activation increases nitroprusside induced apoptosis in human melanoma cells irrespective of p53 status: role of superoxide dismutases

Yim, S.Y.; Chae, K.R.; Shim, S.B.; Hong, J.T.; Park, J.Y.; Lee, C.Y.; Son, H.J.; Sheen, Y.Y.; Hwang, D.Y., 2009:
ERK activation induced by selenium treatment significantly downregulates beta/gamma-secretase activity and Tau phosphorylation in the transgenic rat overexpressing human selenoprotein M

Cho, K-Won.; Cai, J.; Kim, H-Yi.; Hosoya, A.; Ohshima, H.; Choi, K-Yell.; Jung, H-Sung., 2010:
ERK activation is involved in tooth development via FGF10 signaling

Holtz, B.J.; Lodewyk, K.B.; Sebolt-Leopold, J.S.; Ernst, S.A.; Williams, J.A., 2014:
ERK activation is required for CCK-mediated pancreatic adaptive growth in mice

Yuan, L.; Santi, M.; Rushing, E.J.; Cornelison, R.; MacDonald, T.J., 2010:
ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration

Niger, C.; Buo, A.M.; Hebert, C.; Duggan, B.T.; Williams, M.S.; Stains, J.P., 2012:
ERK acts in parallel to PKCδ to mediate the connexin43-dependent potentiation of Runx2 activity by FGF2 in MC3T3 osteoblasts

Jin, F.; Irshad, S.; Yu, W.; Belakavadi, M.; Chekmareva, M.; Ittmann, M.M.; Abate-Shen, C.; Fondell, J.D., 2014:
ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity

Hu, P.; Lai, D.; Lu, P.; Gao, J.; He, H., 2012:
ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells

Cheng, Y.; Qiu, F.; Tashiro, S-ichi.; Onodera, S.; Ikejima, T., 2008:
ERK and JNK mediate TNFalpha-induced p53 activation in apoptotic and autophagic L929 cell death

Ding, Y-Qin.; Jiang, H.; Wang, C-Li., 2012:
ERK and P38MAPK expressions and human sperm motility

Cong, Z-Xiang.; Wang, H-Dong.; Wang, J-Wei.; Zhou, Y.; Pan, H.; Zhang, D-Ding.; Zhu, L., 2014:
ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells

Kordi-Tamandani, D.M.; Saberi, E.; Jamali, S.; Ladiz, M.A.Rigi., 2014:
ERK and RAF1 genes: analysis of methylation and expression profiles in patients with oral squamous cell carcinoma

Čáslavský, J.; Klímová, Z.; Vomastek, Táš., 2014:
ERK and RSK regulate distinct steps of a cellular program that induces transition from multicellular epithelium to single cell phenotype

Rizzo, M.Teresa., 2007:
ERK and Smads: getting together for angiogenic sprouting

Teixeiro, E.; Daniels, M.A., 2010 :
ERK and cell death: ERK location and T cell selection

Subramaniam, S.; Unsicker, K., 2010:
ERK and cell death: ERK1/2 in neuronal death

Martin, P.; Pognonec, P., 2010:
ERK and cell death: cadmium toxicity, sustained ERK activation and cell death

Cagnol, S.; Chambard, J-Claude., 2010:
ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence

Pognonec, P., 2010:
ERK and cell death: overview

Li, X.; Chaudry, I.H.; Choudhry, M.A., 2009:
ERK and not p38 pathway is required for IL-12 restoration of T cell IL-2 and IFN-gamma in a rodent model of alcohol intoxication and burn injury

Ogura, H.; Tsukumo, Y.; Sugimoto, H.; Igarashi, M.; Nagai, K.; Kataoka, T., 2008:
ERK and p38 MAP kinase are involved in downregulation of cell surface TNF receptor 1 induced by acetoxycycloheximide

Ashabi, G.; Ramin, M.; Azizi, P.; Taslimi, Z.; Alamdary, S.Zeighamy.; Haghparast, A.; Ansari, N.; Motamedi, F.; Khodagholi, F., 2012:
ERK and p38 inhibitors attenuate memory deficits and increase CREB phosphorylation and PGC-1α levels in Aβ-injected rats

Li, J.; Zhang, S.; Soto, X.; Woolner, S.; Amaya, E., 2014:
ERK and phosphoinositide 3-kinase temporally coordinate different modes of actin-based motility during embryonic wound healing

Soond, S.M.; Townsend, P.A.; Barry, S.P.; Knight, R.A.; Latchman, D.S.; Stephanou, A., 2008:
ERK and the F-box protein betaTRCP target STAT1 for degradation

Eishingdrelo, H.; Sun, W.; Li, H.; Wang, L.; Eishingdrelo, A.; Dai, S.; McKew, J.C.; Zheng, W., 2015:
ERK and β-arrestin interaction: a converging point of signaling pathways for multiple types of cell surface receptors

Futran, A.S.; Link, A.James.; Seger, R.; Shvartsman, S.Y., 2014:
ERK as a model for systems biology of enzyme kinetics in cells

Liu, H.; Yao, S.; Dann, S.M.; Qin, H.; Elson, C.O.; Cong, Y., 2013:
ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis

Casar, B.; Pinto, Aán.; Crespo, P., 2009:
ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task

Peng, S.; Zhang, Y.; Zhang, J.; Wang, H.; Ren, B., 2010:
ERK in learning and memory: a review of recent research

Hatzivassiliou, G.; Liu, B.; O'Brien, C.; Spoerke, J.M.; Hoeflich, K.P.; Haverty, P.M.; Soriano, R.; Forrest, W.F.; Heldens, S.; Chen, H.; Toy, K.; Ha, C.; Zhou, W.; Song, K.; Friedman, L.S.; Amler, L.C.; Hampton, G.M.; Moffat, J.; Belvin, M.; Lackner, M.R., 2013:
ERK inhibition overcomes acquired resistance to MEK inhibitors

Wang, Y.; Kim, E.; Wang, X.; Novitch, B.G.; Yoshikawa, K.; Chang, L-Sheng.; Zhu, Y., 2012:
ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities

Gladbach, A.; van Eersel, J.; Bi, M.; Ke, Y.D.; Ittner, L.M., 2014:
ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke

Fujita, H.; Asahina, A.; Komine, M.; Tamaki, K., 2007:
ERK inhibitor PD98059 promotes the phenotypic and functional maturation of murine resident Langerhans cells

Su, X.; Wang, X.; Zhang, K.; Yang, S.; Xue, Q.; Wang, P.; Liu, Q., 2014:
ERK inhibitor U0126 enhanced SDT-induced cytotoxicity of human leukemia U937 cells

Ohori, M., 2008:
ERK inhibitors as a potential new therapy for rheumatoid arthritis

Li, N.; McLaren, J.E.; Michael, D.R.; Clement, M.; Fielding, C.A.; Ramji, D.P., 2010:
ERK is integral to the IFN-γ-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages

Dupont, E.; Stevens, L.; Cochon, L.; Falempin, M.; Bastide, B.; Canu, M-Hélène., 2011:
ERK is involved in the reorganization of somatosensory cortical maps in adult rats submitted to hindlimb unloading

Hasegawa, M.; Kondo, M.; Suzuki, I.; Shimizu, N.; Sessle, B.J.; Iwata, K., 2013:
ERK is involved in tooth-pressure-induced Fos expression in Vc neurons

Lin, X.; Yan, J.; Tang, D., 2014:
ERK kinases modulate the activation of PI3 kinase related kinases (PIKKs) in DNA damage response

Heo, J-In.; Oh, S-Jin.; Kho, Y-Jung.; Kim, J-Hyeon.; Kang, H-Joon.; Park, S-Hoon.; Kim, H-Seok.; Shin, J-Yeon.; Kim, M-Ju.; Kim, S.Chan.; Park, J-Bong.; Kim, J.; Lee, J-Yong., 2011:
ERK mediates anti-apoptotic effect through phosphorylation and cytoplasmic localization of p21Waf1/Cip1/Sdi in response to DNA damage in normal human embryonic fibroblast (HEF) cells

Goetz, E.M.; Ghandi, M.; Treacy, D.J.; Wagle, N.; Garraway, L.A., 2015:
ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors

Lidke, D.S.; Huang, F.; Post, J.N.; Rieger, B.; Wilsbacher, J.; Thomas, J.L.; Pouysségur, J.; Jovin, T.M.; Lenormand, P., 2010:
ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation

Waters, K.M.; Cummings, B.S.; Shankaran, H.; Scholpa, N.E.; Weber, T.J., 2015:
ERK oscillation-dependent gene expression patterns and deregulation by stress response

Silingardi, D.; Angelucci, A.; De Pasquale, R.; Borsotti, M.; Squitieri, G.; Brambilla, R.; Putignano, E.; Pizzorusso, T.; Berardi, N., 2012:
ERK pathway activation bidirectionally affects visual recognition memory and synaptic plasticity in the perirhinal cortex

Yin, L-Lin.; Li, W.; Chu, Y-Qi.; Li, L., 2011:
ERK pathway activation is required for amyloid-β(1-40)(-)induced neurotoxicity of THP-1 human monocytes towards SK-N-SH neuroblastoma

Nissan, M.H.; Rosen, N.; Solit, D.B., 2014:
ERK pathway inhibitors: how low should we go?

Park, E-Jung.; Umh, H.Nee.; Kim, S-Wook.; Cho, M-Haing.; Kim, J-Ho.; Kim, Y., 2014:
ERK pathway is activated in bare-FeNPs-induced autophagy

Caunt, C.J.; McArdle, C.A., 2012:
ERK phosphorylation and nuclear accumulation: insights from single-cell imaging

Gupta, S.; Booth, J.W., 2010:
ERK phosphorylation and tumor necrosis factor-alpha production by monocytes are persistent in response to immobilized IgG

Du, T.; Li, B.; Liu, S.; Zang, P.; Prevot, V.; Hertz, L.; Peng, L., 2009:
ERK phosphorylation in intact, adult brain by alpha(2)-adrenergic transactivation of EGF receptors

Kim, S.Wook.; Kim, H.Kyung.; Lee, J.In.; Jang, H.Won.; Choe, J-Ho.; Kim, J-Han.; Kim, J.Soo.; Hur, K.Yeon.; Kim, J.Hyeon.; Chung, J.Hoon., 2013:
ERK phosphorylation is not increased in papillary thyroid carcinomas with BRAF(V600E) mutation compared to that of corresponding normal thyroid tissues

Zinn, R.L.; Gardner, E.E.; Marchionni, L.; Murphy, S.C.; Dobromilskaya, I.; Hann, C.L.; Rudin, C.M., 2014:
ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer

Das, A.; Salloum, F.N.; Xi, L.; Rao, Y.J.; Kukreja, R.C., 2009:
ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice

Galbraith, M.D.; Saxton, J.; Li, L.; Shelton, S.J.; Zhang, H.; Espinosa, J.M.; Shaw, P.E., 2014:
ERK phosphorylation of MED14 in promoter complexes during mitogen-induced gene activation by Elk-1

Luk, P.P.; Galettis, P.; Links, M., 2011:
ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478

Vanderheyden, W.M.; Gerstner, J.R.; Tanenhaus, A.; Yin, J.C.; Shaw, P.J., 2015:
ERK phosphorylation regulates sleep and plasticity in Drosophila

May, L.T.; Hill, S.J., 2008:
ERK phosphorylation: spatial and temporal regulation by G protein-coupled receptors

Dent, P., 2014:
ERK plays the baddie (again)

Helou, Y.A.; Nguyen, V.; Beik, S.P.; Salomon, A.R., 2014:
ERK positive feedback regulates a widespread network of tyrosine phosphorylation sites across canonical T cell signaling and actin cytoskeletal proteins in Jurkat T cells

Bisel, B.; Wang, Y.; Wei, J-Hsuan.; Xiang, Y.; Tang, D.; Miron-Mendoza, M.; Yoshimura, S-ichiro.; Nakamura, N.; Seemann, J., 2008:
ERK regulates Golgi and centrosome orientation towards the leading edge through GRASP65

Chen, H.; Libertini, S.J.; Wang, Y.; Kung, H-Jien.; Ghosh, P.; Mudryj, M., 2010:
ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines

Okumura, Y.; Sugiyama, N.; Tanimura, S.; Nishida, M.; Hamaoka, K.; Kohno, M.; Yokoyama, T., 2009:
ERK regulates renal cell proliferation and renal cyst expansion in inv mutant mice

Gayer, C.P.; Craig, D.H.; Flanigan, T.L.; Reed, T.D.; Cress, D.E.; Basson, M.D., 2010:
ERK regulates strain-induced migration and proliferation from different subcellular locations

Song, R.S.; Massenburg, B.; Wenderski, W.; Jayaraman, V.; Thompson, L.; Neves, S.R., 2013:
ERK regulation of phosphodiesterase 4 enhances dopamine-stimulated AMPA receptor membrane insertion

Tasaki, J.; Shibata, N.; Nishimura, O.; Itomi, K.; Tabata, Y.; Son, F.; Suzuki, N.; Araki, R.; Abe, M.; Agata, K.; Umesono, Y., 2011:
ERK signaling controls blastema cell differentiation during planarian regeneration

Xu, J.; Hopkins, K.; Sabin, L.; Yasunaga, A.; Subramanian, H.; Lamborn, I.; Gordesky-Gold, B.; Cherry, S., 2013:
ERK signaling couples nutrient status to antiviral defense in the insect gut

Bliss, S.P.; Miller, A.; Navratil, A.M.; Xie, J.; McDonough, S.P.; Fisher, P.J.; Landreth, G.E.; Roberson, M.S., 2009:
ERK signaling in the pituitary is required for female but not male fertility

He, K.; Aizenman, E., 2010:
ERK signaling leads to mitochondrial dysfunction in extracellular zinc-induced neurotoxicity

Guo, X-Ling.; Deng, Y.; Shang, J.; Liu, K.; Xu, Y-Jian.; Liu, H-Guo., 2014 :
ERK signaling mediates enhanced angiotensin II-induced rat aortic constriction following chronic intermittent hypoxia

Gao, Z.; Hu, Y.; Peng, J.; Deng, Z.; Liang, G.; Jiang, H.; Zhou, J., 2013:
ERK signaling pathway mediated epithelial-mesenchymal transition induced by SiO₂ in human bronchial epithelial cells

Li, L.; Wang, L.; Li, T-T.; Li, X.; Huang, X-Q.; Chen, X-W.; Li, Z-L.; Lv, X-M.; Liu, F-Y.; Luo, Z-W.; Liu, M.; Hu, X-H.; Hu, W-F.; Huang, Z-X.; Yi, M.; Liu, S-J.; Liu, Y-Z.; Li, D.W-C., 2014:
ERK signaling pathway regulates embryonic survival and eye development in goldfish, Carassius auratus

Seo, S.W.; Lee, D.; Cho, S.K.; Kim, A.D.; Minematsu, H.; Celil Aydemir, A.B.; Geller, J.A.; Macaulay, W.; Yang, J.; Lee, F.Young.; Young-In Lee, F., 2007:
ERK signaling regulates macrophage colony-stimulating factor expression induced by titanium particles in MC3T3.E1 murine calvarial preosteoblastic cells

Adiseshaiah, P.; Li, J.; Vaz, M.; Kalvakolanu, D.V.; Reddy, S.P., 2008:
ERK signaling regulates tumor promoter induced c-Jun recruitment at the Fra-1 promoter

Maćkowiak, M.; Dudys, D.; Wedzony, K., 2010:
ERK signalling pathway is not involved in PSA-NCAM-dependent alterations of hippocampal plasticity evoked by CB1 receptor activation

Kittilson, J.D.; Jones, E.; Sheridan, M.A., 2011:
ERK, Akt, and STAT5 are Differentially Activated by the Two Growth Hormone Receptor Subtypes of a Teleost Fish (Oncorhynchus Mykiss)

Jia, X-wei.; Liu, B-ci.; Shi, X-lin.; Gao, A.; Ye, M.; Zhang, F-mei.; Liu, H-feng.; Jiao, S., 2008:
ERK, JNK/AP-1 pathway was involved in silica-induced cell cycle changes

Min, M-Yuan.; Yang, H-Wen.; Yen, C-Tung.; Chen, C-Chang.; Chen, C-Cheng.; Cheng, S-Jhong., 2011:
ERK, synaptic plasticity and acid-induced muscle pain

Shen, J.; Wu, Y.; Xu, J-Ying.; Zhang, J.; Sinclair, S.H.; Yanoff, M.; Xu, G.; Li, W.; Xu, G-Tong., 2010:
ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD

Pucci, B.; Indelicato, M.; Paradisi, V.; Reali, V.; Pellegrini, L.; Aventaggiato, M.; Karpinich, N.O.; Fini, M.; Russo, M.A.; Farber, J.L.; Tafani, M., 2010:
ERK-1 MAP kinase prevents TNF-induced apoptosis through bad phosphorylation and inhibition of Bax translocation in HeLa Cells

Prasadam, I.; van Gennip, S.; Friis, T.; Shi, W.; Crawford, R.; Xiao, Y., 2010:
ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts

Ben-Chetrit, N.; Tarcic, G.; Yarden, Y., 2012:
ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype

Mendoza, M.C.; Er, E.Emrah.; Blenis, J., 2010:
ERK-MAP Kinase signaling in the cytoplasm

Mendoza, M.C.; Er, E.Emrah.; Zhang, W.; Ballif, B.A.; Elliott, H.L.; Danuser, G.; Blenis, J., 2011:
ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex

Zhang, J.; Bian, H-Jun.; Li, X-Xing.; Liu, X-Bo.; Sun, J-Ping.; Li, N.; Zhang, Y.; Ji, X-Ping., 2010:
ERK-MAPK signaling opposes rho-kinase to reduce cardiomyocyte apoptosis in heart ischemic preconditioning

Guedea, A.L.; Schrick, C.; Guzman, Y.F.; Leaderbrand, K.; Jovasevic, V.; Corcoran, K.A.; Tronson, N.C.; Radulovic, J., 2011:
ERK-associated changes of AP-1 proteins during fear extinction

Singh, K.; Deshpande, P.; Pryshchep, S.; Colmegna, Iés.; Liarski, V.; Weyand, C.M.; Goronzy, Jörg.J., 2010:
ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis

Li, X.; Bian, Y.; Takizawa, Y.; Hashimoto, T.; Ikoma, T.; Tanaka, J.; Kitamura, N.; Inagaki, Y.; Komada, M.; Tanaka, T., 2014:
ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression

Savino, B.; Caronni, N.; Anselmo, A.; Pasqualini, F.; Borroni, E.Monica.; Basso, G.; Celesti, G.; Laghi, L.; Tourlaki, A.; Boneschi, V.; Brambilla, L.; Nebuloni, M.; Vago, G.; Mantovani, A.; Locati, M.; Bonecchi, R., 2015:
ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma

Besirli, C.G.; Zheng, Q-Duon.; Reed, D.M.; Zacks, D.N., 2013:
ERK-mediated activation of Fas apoptotic inhibitory molecule 2 (Faim2) prevents apoptosis of 661W cells in a model of detachment-induced photoreceptor cell death

Wang, K.Z.Q.; Zhu, J.; Dagda, R.K.; Uechi, G.; Cherra, S.J.; Gusdon, A.M.; Balasubramani, M.; Chu, C.T., 2015:
ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: implications for Parkinson's disease

Zakrzewska, M.; Haugsten, E.Margrethe.; Nadratowska-Wesolowska, B.; Oppelt, A.; Hausott, B.; Jin, Y.; Otlewski, J.; Wesche, Jørgen.; Wiedlocha, A., 2013:
ERK-mediated phosphorylation of fibroblast growth factor receptor 1 on Ser777 inhibits signaling

Pergola, C.; Dodt, G.; Rossi, A.; Neunhoeffer, E.; Lawrenz, B.; Northoff, H.; Samuelsson, B.; Rådmark, O.; Sautebin, L.; Werz, O., 2009:
ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma

Tsai, S-Chang.; Huang, W-Wen.; Huang, W-Chien.; Lu, C-Cheng.; Chiang, J-Hua.; Peng, S-Fen.; Chung, J-Gung.; Lin, Y-Hsin.; Hsu, Y-Man.; Amagaya, S.; Yang, J-Sing., 2013:
ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells

Primot, A.; Mogha, A.; Corre, Sébastien.; Roberts, K.; Debbache, J.; Adamski, H.; Dreno, B.; Khammari, A.; Lesimple, T.; Mereau, A.; Goding, C.R.; Galibert, M-Dominique., 2010:
ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma

Galante, J.M.; Mortenson, M.M.; Bowles, T.L.; Virudachalam, S.; Bold, R.J., 2008:
ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis

Wang, G-Sheng.; Huang, Y-Gang.; Li, H.; Bi, S-Jie.; Zhao, J-Long., 2014:
ERK/CANP rapid signaling mediates 17β-estradiol-induced proliferation of human breast cancer cell line MCF-7 cells

Lin, K.; Fang, S.; Cai, B.; Huang, X.; Zhang, X.; Lu, Y.; Zhang, W.; Wei, E., 2015:
ERK/Egr-1 signaling pathway is involved in CysLT2 receptor-mediated IL-8 production in HEK293 cells

Nagarajan, D.; Melo, T.; Deng, Z.; Almeida, C.; Zhao, W., 2012:
ERK/GSK3β/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition

Liu, L.; Zhang, H.; Sun, L.; Gao, Y.; Jin, H.; Liang, S.; Wang, Y.; Dong, M.; Shi, Y.; Li, Z.; Fan, D., 2010:
ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer

Karmarkar, S.W.; Bottum, K.M.; Krager, S.L.; Tischkau, S.A., 2012:
ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells

Park, S.; Jung, H.Hyun.; Park, Y.Hee.; Ahn, J.Seok.; Im, Y-Hyuck., 2011:
ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression

Heckler, M.M.; Thakor, H.; Schafer, C.C.; Riggins, R.B., 2014:
ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer

Azzam, D.G.; Tay, J.W.T.; Greeve, M.A.; Harvey, J.M.; Bentel, J.M., 2008:
ERK/MAPK regulation of the androgen responsiveness of breast cancer cells

Wu, X.; Xu, T.; Li, D.; Zhu, S.; Chen, Q.; Hu, W.; Pan, D.; Zhu, H.; Sun, H., 2014:
ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion

Karakhanova, S.; Meisel, S.; Ring, S.; Mahnke, K.; Enk, A.H., 2010:
ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets

Dissanayake, K.; Toth, R.; Blakey, J.; Olsson, O.; Campbell, D.G.; Prescott, A.R.; MacKintosh, C., 2011:
ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa

Oh, Y-Take.; Liu, X.; Yue, P.; Kang, S.; Chen, J.; Taunton, J.; Khuri, F.R.; Sun, S-Yong., 2011:
ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1

Krens, S.F.Gabby.; Corredor-Adámez, M.; He, S.; Snaar-Jagalska, B.Ewa.; Spaink, H.P., 2008:
ERK1 and ERK2 MAPK are key regulators of distinct gene sets in zebrafish embryogenesis

Donzelli, E.; Lucchini, C.; Ballarini, E.; Scuteri, A.; Carini, F.; Tredici, G.; Miloso, M., 2011:
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation

Imamura, O.; Pagès, G.; Pouysségur, J.; Endo, S.; Takishima, K., 2011:
ERK1 and ERK2 are required for radial glial maintenance and cortical lamination

Wei, F.; Xie, Y.; He, L.; Tao, L.; Tang, D., 2011:
ERK1 and ERK2 kinases activate hydroxyurea-induced S-phase checkpoint in MCF7 cells by mediating ATR activation

Chen, Z.; Yue, S.X.; Zhou, G.; Greenfield, E.M.; Murakami, S., 2016:
ERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formation

Goplen, N.; Karim, Z.; Guo, L.; Zhuang, Y.; Huang, H.; Gorska, M.M.; Gelfand, E.; Pagés, G.; Pouysségur, J.; Alam, R., 2012:
ERK1 is important for Th2 differentiation and development of experimental asthma

Marchi, M.; Pancrazi, L.; Maffei, M.; Ratto, G.Michele.; Costa, M., 2010:
ERK1 nucleocytoplasmic shuttling rate depends on specific N-terminal aminoacids

Kim, S-Hyun.; Kim, M.Ok.; Cho, Y-Yeon.; Yao, K.; Kim, D.Joon.; Jeong, C-Ho.; Yu, D.Hoon.; Bae, K.Beom.; Cho, E.Jin.; Jung, S.Keun.; Lee, M.Hyun.; Chen, H.; Kim, J.Young.; Bode, A.M.; Dong, Z., 2015:
ERK1 phosphorylates Nanog to regulate protein stability and stem cell self-renewal

Saulnier, N.; Guihard, S.; Holy, X.; Decembre, E.; Jurdic, P.; Clay, D.; Feuillet, V.; Pagès, G.; Pouysségur, J.; Porteu, Fçoise.; Gaudry, M., 2012:
ERK1 regulates the hematopoietic stem cell niches

Yang, Y.; Lee, G.Jun.; Yoon, D.Hyo.; Yu, T.; Oh, J.; Jeong, D.; Lee, J.; Kim, S.Hwan.; Kim, T.Woong.; Cho, J.Youl., 2013:
ERK1- and TBK1-targeted anti-inflammatory activity of an ethanol extract of Dryopteris crassirhizoma

Cisse, M.; Braun, U.; Leitges, M.; Fisher, A.; Pages, G.; Checler, Fédéric.; Vincent, B., 2011:
ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/ε

Rodríguez, J.; Calvo, F.; González, Jé.M.; Casar, B.; Andrés, V.; Crespo, P., 2011:
ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes

Roskoski, R., 2012:
ERK1/2 MAP kinases: structure, function, and regulation

Vleugels, K.; Schinner, S.; Krause, D.; Morawietz, H.; Bornstein, S.R.; Ehrhart-Bornstein, M.; Krug, A.W., 2012:
ERK1/2 MAPKs and Wnt signaling pathways are independently involved in adipocytokine-mediated aldosterone secretion

Sbroggiò, M.; Bertero, A.; Velasco, S.; Fusella, F.; De Blasio, E.; Bahou, W.F.; Silengo, L.; Turco, E.; Brancaccio, M.; Tarone, G., 2012:
ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1

Li, Y-Qin.; Xue, T.; Xu, J.; Xu, Z-Cai.; Liu, H.; Chen, Y-Mei., 2010:
ERK1/2 activation in reactive astrocytes of mice with pilocarpine-induced status epilepticus

Djouad, F.; Rackwitz, L.; Song, Y.; Janjanin, S.; Tuan, R.S., 2009:
ERK1/2 activation induced by inflammatory cytokines compromises effective host tissue integration of engineered cartilage

Dridi, S.; Hirano, Y.; Tarallo, V.; Kim, Y.; Fowler, B.J.; Ambati, B.K.; Bogdanovich, S.; Chiodo, V.A.; Hauswirth, W.W.; Kugel, J.F.; Goodrich, J.A.; Ponicsan, S.L.; Hinton, D.R.; Kleinman, M.E.; Baffi, J.Z.; Gelfand, B.D.; Ambati, J., 2012:
ERK1/2 activation is a therapeutic target in age-related macular degeneration

Lee, S-Young.; Shin, S.Joon.; Kim, H-Shik., 2013:
ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53

Forbes, A.; Davey, A.K.; Perkins, A.V.; Grant, G.D.; McFarland, A.J.; McDermott, C.M.; Anoopkumar-Dukie, S., 2014:
ERK1/2 activation modulates pyocyanin-induced toxicity in A549 respiratory epithelial cells

Zhang, Y.; Yu, G.; Wang, D.; Hu, Y.; Lei, W., 2011:
ERK1/2 activation plays important roles in the opposite effects of Trichostatin A in non-cancer and cancer cells

Chen, W-Li.; Lin, C-Tien.; Li, J-Wen.; Hu, F-Rong.; Chen, C-Chow., 2009:
ERK1/2 activation regulates the wound healing process of rabbit corneal endothelial cells

Zheng, C.; Jiao, X.; Jiang, Y.; Sun, S., 2014:
ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells

Meng, L.; Tao, H.; Dong, G.; Yang, T.; Zhang, W.; Zhu, W.; Huang, C., 2012:
ERK1/2 and Akt pathway activated during (3R,6R)-bassiatin(1)-induced apoptosis in MCF-7 cells

Cammarota, Mín.; Bevilaqua, L.R.; Medina, J.H.; Izquierdo, Ián., 2008:
ERK1/2 and CaMKII-mediated events in memory formation: is 5HT regulation involved?

Su, C.; Underwood, W.; Rybalchenko, N.; Singh, M., 2012:
ERK1/2 and ERK5 have distinct roles in the regulation of brain-derived neurotrophic factor expression

Boaglio, A.C.; Zucchetti, Aés.E.; Toledo, F.D.; Barosso, I.R.; Sánchez Pozzi, E.J.; Crocenzi, F.A.; Roma, M.G., 2013:
ERK1/2 and p38 MAPKs are complementarily involved in estradiol 17ß-D-glucuronide-induced cholestasis: crosstalk with cPKC and PI3K

Sosa, M.Soledad.; Avivar-Valderas, A.; Bragado, P.; Wen, H-Chi.; Aguirre-Ghiso, J.A., 2012:
ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease

Hwang, S-Lark.; Lu, Y.; Li, X.; Kim, Y.Deuk.; Cho, Y.Sook.; Jahng, Y.; Son, J-Keun.; Lee, Y.Ju.; Kang, W.; Taketomi, Y.; Murakami, M.; Moon, T.Chul.; Chang, H.Wook., 2015:
ERK1/2 antagonize AMPK-dependent regulation of FcεRI-mediated mast cell activation and anaphylaxis

Mayorov, D.N., 2007 :
ERK1/2 as a molecular switch for the initiation of long-term pressor response to central angiotensin II

Buonato, J.M.; Lazzara, M.J., 2014:
ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition

Yang, H.; Nie, Y.; Li, Y.; Wan, Y-Jui.Yvonne., 2011:
ERK1/2 deactivation enhances cytoplasmic Nur77 expression level and improves the apoptotic effect of fenretinide in human liver cancer cells

Kosari, S.; Camera, D.M.; Hawley, J.A.; Stebbing, M.; Badoer, E., 2013:
ERK1/2 in the brain mediates the effects of central resistin on reducing thermogenesis in brown adipose tissue

Moosavi, M.Amin.; Yazdanparast, R.; Lotfi, A., 2007:
ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells

Qian, C.; Yao, J.; Wang, J.; Wang, L.; Xue, M.; Zhou, T.; Liu, W.; Si, J., 2014:
ERK1/2 inhibition enhances apoptosis induced by JAK2 silencing in human gastric cancer SGC7901 cells

Kilanczyk, E.; Filipek, S.; Filipek, A., 2011:
ERK1/2 is dephosphorylated by a novel phosphatase--CacyBP/SIP

Chen, W.; Ma, Y.; Ye, H.; He, Y.; Li, X.; Li, J.; Zhu, Z.; Wang, H., 2010:
ERK1/2 is involved in cyclic compressive force-induced IL-6 secretion in MLO-Y4 cells

Choi, J.; Jo, M.; Lee, E.; Choi, D., 2015:
ERK1/2 is involved in luteal cell autophagy regulation during corpus luteum regression via an mTOR-independent pathway

Jerjees, D.A.; Alabdullah, M.; Alkaabi, M.; Abduljabbar, R.; Muftah, A.; Nolan, C.; Green, A.R.; Ellis, I.O.; Rakha, E.A., 2015 :
ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer

Yin, J.; Yu, F-Shin.X., 2008:
ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding

Sáenz-Morales, D.; Conde, E.; Escribese, Mía.M.; García-Martos, Mía.; Alegre, L.; Blanco-Sánchez, I.; García-Bermejo, Mía.Laura., 2009:
ERK1/2 mediates cytoskeleton and focal adhesion impairment in proximal epithelial cells after renal ischemia

Huang, Y.; Wang, X-yu.; Fu, L.; Yang, C-tao.; Mo, L-qiu.; Yang, Z-li.; Dong, X-bian.; Liao, X-xue.; Feng, J-qiang., 2013:
ERK1/2 mediates edaravone-triggered protection against myocardial damage induced by isoprenaline in H9c2 cells

Yang, L.; Su, T.; Lv, D.; Xie, F.; Liu, W.; Cao, J.; Sheikh, I.Ali.; Qin, X.; Li, L.; Chen, L., 2014:
ERK1/2 mediates lung adenocarcinoma cell proliferation and autophagy induced by apelin-13

Jaldety, Y.; Breitbart, H., 2016:
ERK1/2 mediates sperm acrosome reaction through elevation of intracellular calcium concentration

Stamboulian, S.; Choi, J-Sung.; Ahn, H-Sook.; Chang, Y-Wen.; Tyrrell, L.; Black, J.A.; Waxman, S.G.; Dib-Hajj, S.D., 2010:
ERK1/2 mitogen-activated protein kinase phosphorylates sodium channel Na(v)1.7 and alters its gating properties

Tan, J.Cheng.; Cui, W.Xia.; Heng, D.; Lin, L., 2015:
ERK1/2 participates in regulating the expression and distribution of tight junction proteins in the process of reflux esophagitis

Métrailler, S.; Emery, M.; Schorderet, D.F.; Cottet, S.; Roduit, R., 2014:
ERK1/2 pathway is activated in degenerated Rpe65-deficient mice

Chen, X.; Ye, S.; Xiao, W.; Wang, W.; Luo, L.; Liu, Y., 2014:
ERK1/2 pathway mediates epithelial-mesenchymal transition by cross-interacting with TGFβ/Smad and Jagged/Notch signaling pathways in lens epithelial cells

Shi, B.; Ding, J.; Liu, Y.; Zhuang, X.; Zhuang, X.; Chen, X.; Fu, C., 2015:
ERK1/2 pathway-mediated differentiation of IGF-1-transfected spinal cord-derived neural stem cells into oligodendrocytes

Carriere, A.; Romeo, Y.; Acosta-Jaquez, H.A.; Moreau, J.; Bonneil, E.; Thibault, P.; Fingar, D.C.; Roux, P.P., 2011:
ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1)

Gai, B.Mozzaquatro.; Sanna, M.Domenica.; Stein, Aé.Luiz.; Zeni, G.; Galeotti, N.; Nogueira, C.Wayne., 2015:
ERK1/2 phosphorylation is involved in the antidepressant-like action of 2,5-diphenyl-3-(4-fluorophenylseleno)-selenophene in mice

Yu, M-Qing.; Liu, X-Sheng.; Wu, H-Xu.; Xiang, M.; Xu, Y-Jian., 2014:
ERK1/2 promotes cigarette smoke-induced rat pulmonary artery smooth muscle cells proliferation and pulmonary vascular remodeling via up-regulating cycline1 expression

Lenz, B.; Klafki, H-Wolfgang.; Hillemacher, T.; Frieling, H.; Clepce, M.; Gossler, A.; Thuerauf, N.; Winterer, G.; Kornhuber, J.; Bleich, S., 2013:
ERK1/2 protein and mRNA levels in human blood are linked to smoking behavior

Ren, J.; Guo, W., 2012:
ERK1/2 regulate exocytosis through direct phosphorylation of the exocyst component Exo70

Soubeyrand, Sébastien.; Naing, T.; Martinuk, A.; McPherson, R., 2014:
ERK1/2 regulates hepatocyte Trib1 in response to mitochondrial dysfunction

Marshall, A.K.; Barrett, O.P.T.; Cullingford, T.E.; Shanmugasundram, A.; Sugden, P.H.; Clerk, A., 2011:
ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes

Murcia-Belmonte, Vónica.; Medina-Rodríguez, E.M.; Bribián, A.; de Castro, F.; Esteban, P.F., 2015:
ERK1/2 signaling is essential for the chemoattraction exerted by human FGF2 and human anosmin-1 on newborn rat and mouse OPCs via FGFR1

Gao, G.; Ouyang, A.; Kaufman, M.P.; Yu, S., 2011:
ERK1/2 signaling pathway in mast cell activation-induced sensitization of esophageal nodose C-fiber neurons

Ye, X.; Ren, H.; Zhang, M.; Sun, Z.; Jiang, A.C.; Xu, G., 2012:
ERK1/2 signaling pathway in the release of VEGF from Müller cells in diabetes

Xie, M.; Liu, X-Sheng.; Xu, Y-Jian.; Zhang, Z-Xiang.; Bai, J.; Ni, W.; Chen, S-Xin., 2007:
ERK1/2 signaling pathway modulates the airway smooth muscle cell phenotype in the rat model of chronic asthma

Ye, X.; Xu, G.; Chang, Q.; Fan, J.; Sun, Z.; Qin, Y.; Jiang, A.C., 2010:
ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina

Kolb, R.H.; Greer, P.M.; Cao, P.T.; Cowan, K.H.; Yan, Y., 2013:
ERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation

Chen, L.; Pan, Y.; Gu, L.; Nie, Z.; He, B.; Song, G.; Li, R.; Xu, Y.; Gao, T.; Wang, S., 2014:
ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion

Ren, B.; Deng, Y.; Mukhopadhyay, A.; Lanahan, A.A.; Zhuang, Z.W.; Moodie, K.L.; Mulligan-Kehoe, M.Jo.; Byzova, T.V.; Peterson, R.T.; Simons, M., 2010:
ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish

Zhang, J.; Song, J.; Xu, J.; Chen, X.; Yin, P.; Lv, X.; Wang, X., 2014:
ERK1/2-Egr-1 Signaling Pathway-Mediated Protective Effects of Electroacupuncture in a Mouse Model of Myocardial Ischemia-Reperfusion

Parrales, A.; López, E.; Lee-Rivera, I.; López-Colomé, A.María., 2013:
ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation

Spirli, C.; Okolicsanyi, S.; Fiorotto, R.; Fabris, L.; Cadamuro, M.; Lecchi, S.; Tian, X.; Somlo, S.; Strazzabosco, M., 2010:
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice

Seo, T.Beom.; Oh, M-Jin.; You, B-Gun.; Kwon, K-Birm.; Chang, I-Ae.; Yoon, J-Hwan.; Lee, C-Yong.; Namgung, U., 2010:
ERK1/2-mediated Schwann cell proliferation in the regenerating sciatic nerve by treadmill training

Chen, Y-Shun.; Huang, W-Hung.; Hong, S-Ya.; Tsay, Y-Guang.; Chen, P-Jer., 2008:
ERK1/2-mediated phosphorylation of small hepatitis delta antigen at serine 177 enhances hepatitis delta virus antigenomic RNA replication

Li, T.; Hu, J.; Du, S.; Chen, Y.; Wang, S.; Wu, Q., 2015:
ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes

Ishii, A.; Fyffe-Maricich, S.L.; Furusho, M.; Miller, R.H.; Bansal, R., 2012:
ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination

Mahalingam, M.; Arvind, R.; Ida, H.; Murugan, A.Kannan.; Yamaguchi, M.; Tsuchida, N., 2008:
ERK2 CD domain mutation from a human cancer cell line enhanced anchorage-independent cell growth and abnormality in Drosophila

Abdel-Magid, A.F., 2014:
ERK2 Inhibitors May Provide Treatment for Cancer

Shin, S.; Dimitri, C.A.; Yoon, S-Oh.; Dowdle, W.; Blenis, J., 2010:
ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events

Satoh, Y.; Endo, S.; Nakata, T.; Kobayashi, Y.; Yamada, K.; Ikeda, T.; Takeuchi, A.; Hiramoto, T.; Watanabe, Y.; Kazama, T., 2011:
ERK2 contributes to the control of social behaviors in mice

von Thun, A.; Birtwistle, M.; Kalna, G.; Grindlay, J.; Strachan, D.; Kolch, W.; von Kriegsheim, A.; Norman, J.C., 2013:
ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and liprin-β2

Shukla, A.; Hillegass, J.M.; MacPherson, M.B.; Beuschel, S.L.; Vacek, P.M.; Butnor, K.J.; Pass, H.I.; Carbone, M.; Testa, J.R.; Heintz, N.H.; Mossman, B.T., 2011:
ERK2 is essential for the growth of human epithelioid malignant mesotheliomas

Steinacker, P.; Klafki, H.; Lehnert, S.; Jesse, S.; Arnim, C.A.F.V.; Tumani, H.; Pabst, A.; Kretzschmar, H.A.; Wiltfang, J.; Otto, M., 2011:
ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients

Zhang, C.; Kong, X.; Liu, C.; Liang, Z.; Zhao, H.; Tong, W.; Ning, G.; Shen, W.; Yao, L.; Feng, S., 2014:
ERK2 small interfering RNAs prevent epidural fibrosis via the efficient inhibition of collagen expression and inflammation in laminectomy rats

Hamilton, W.B.; Kaji, K.; Kunath, T., 2013:
ERK2 suppresses self-renewal capacity of embryonic stem cells, but is not required for multi-lineage commitment

Aceves-Luquero, C.I.; Agarwal, A.; Callejas-Valera, J.L.; Arias-González, L.; Esparís-Ogando, A.; del Peso Ovalle, L.; Bellón-Echeverria, I.; de la Cruz-Morcillo, M.A.; Galán Moya, E.M.; Moreno Gimeno, I.; Gómez, J.C.; Deininger, M.W.; Pandiella, A.; Sánchez Prieto, R., 2009:
ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy

Miura, K., 2008:
ERK2-binding domain is required for phosphorylation of EBITEIN1, a potential downstream interactor of ERK2

Toulany, M.; Minjgee, M.; Saki, M.; Holler, M.; Meier, F.; Eicheler, W.; Rodemann, H.Peter., 2014:
ERK2-dependent reactivation of Akt mediates the limited response of tumor cells with constitutive K-RAS activity to PI3K inhibition

Funahashi, Y.; Namba, T.; Fujisue, S.; Itoh, N.; Nakamuta, S.; Kato, K.; Shimada, A.; Xu, C.; Shan, W.; Nishioka, T.; Kaibuchi, K., 2013:
ERK2-mediated phosphorylation of Par3 regulates neuronal polarization

Kapadia, B.; Viswakarma, N.; Parsa, K.V.L.; Kain, V.; Behera, S.; Suraj, S.Kaimal.; Babu, P.Prakash.; Kar, A.; Panda, S.; Zhu, Y-jun.; Jia, Y.; Thimmapaya, B.; Reddy, J.K.; Misra, P., 2014:
ERK2-mediated phosphorylation of transcriptional coactivator binding protein PIMT/NCoA6IP at Ser298 augments hepatic gluconeogenesis

Botta, G.P.; Reichert, M.; Reginato, M.J.; Heeg, S.; Rustgi, A.K.; Lelkes, P.I., 2013:
ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells

Shin, S.; Blenis, J., 2011:
ERK2/Fra1/ZEB pathway induces epithelial-to-mesenchymal transition

Li, S.; Ou, X-Hong.; Wang, Z-Bo.; Xiong, B.; Tong, J-Shan.; Wei, L.; Li, M.; Yuan, J.; Ouyang, Y-Chun.; Hou, Y.; Schatten, H.; Sun, Q-Yuan., 2011:
ERK3 is required for metaphase-anaphase transition in mouse oocyte meiosis

Wang, W.; Bian, K.; Vallabhaneni, S.; Zhang, B.; Wu, R-Chang.; O'Malley, B.W.; Long, W., 2014:
ERK3 promotes endothelial cell functions by upregulating SRC-3/SP1-mediated VEGFR2 expression

Long, W.; Foulds, C.E.; Qin, J.; Liu, J.; Ding, C.; Lonard, D.M.; Solis, L.M.; Wistuba, I.I.; Qin, J.; Tsai, S.Y.; Tsai, M-Jer.; O'Malley, B.W., 2012 :
ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion

Wu, Y.; Zuo, Y.; Chakrabarti, R.; Feng, B.; Chen, S.; Chakrabarti, S., 2010:
ERK5 Contributes to VEGF Alteration in Diabetic Retinopathy

Cundiff, P.; Liu, L.; Wang, Y.; Zou, J.; Pan, Y-Wei.; Abel, G.; Duan, X.; Ming, G-Li.; Englund, C.; Hevner, R.; Xia, Z., 2009:
ERK5 MAP kinase regulates neurogenin1 during cortical neurogenesis

Wu, Y.; Feng, B.; Chen, S.; Chakrabarti, S., 2013:
ERK5 Regulates glucose-induced increased fibronectin production in the endothelial cells and in the retina in diabetes

Sánchez-Fernández, Gán.; Cabezudo, Sía.; García-Hoz, C.; Tobin, A.B.; Mayor, F.; Ribas, C., 2014:
ERK5 activation by Gq-coupled muscarinic receptors is independent of receptor internalization and β-arrestin recruitment

Urushihara, M.; Takamatsu, M.; Shimizu, M.; Kondo, S.; Kinoshita, Y.; Suga, K.; Kitamura, A.; Matsuura, S.; Yoshizumi, M.; Tamaki, T.; Kawachi, H.; Kagami, S., 2010:
ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis

Heo, K-Sun.; Cushman, H.J.; Akaike, M.; Woo, C-Hoon.; Wang, X.; Qiu, X.; Fujiwara, K.; Abe, J-ichi., 2014:
ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis

Obara, Y.; Yamauchi, A.; Takehara, S.; Nemoto, W.; Takahashi, M.; Stork, P.J.S.; Nakahata, N., 2009:
ERK5 activity is required for nerve growth factor-induced neurite outgrowth and stabilization of tyrosine hydroxylase in PC12 cells

Lochhead, P.A.; Gilley, R.; Cook, S.J., 2012:
ERK5 and its role in tumour development

Roberts, O.Llŷr.; Holmes, K.; Müller, Jürgen.; Cross, D.A.E.; Cross, M.J., 2010:
ERK5 and the regulation of endothelial cell function

Kim, S.; Lim, J.Hyang.; Woo, C-Hoon., 2014:
ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation

Roberts, O.Llŷr.; Holmes, K.; Müller, Jürgen.; Cross, D.A.E.; Cross, M.J., 2010:
ERK5 is required for VEGF-mediated survival and tubular morphogenesis of primary human microvascular endothelial cells

Wang, Y-Sheng.; Zhou, J.; Liang, C.; Hong, K.; Cheng, X-Shu.; Wu, Z-Gui., 2014:
ERK5 knock down aggravates detrimental effects of hypothermal stimulation on cardiomyocytes via Bim upregulation

Charni, S.; Aguilo, J.Ignacio.; Garaude, J.; de Bettignies, G.; Jacquet, C.; Hipskind, R.A.; Singer, D.; Anel, A.; Villalba, M., 2009:
ERK5 knockdown generates mouse leukemia cells with low MHC class I levels that activate NK cells and block tumorigenesis

Iñesta-Vaquera, F.A.; Campbell, D.G.; Arthur, J.Simon.C.; Cuenda, A., 2010:
ERK5 pathway regulates the phosphorylation of tumour suppressor hDlg during mitosis

Wang, X.; Pesakhov, S.; Harrison, J.S.; Danilenko, M.; Studzinski, G.P., 2014:
ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells

Wilhelmsen, K.; Mesa, K.R.; Lucero, J.; Xu, F.; Hellman, J., 2012:
ERK5 protein promotes, whereas MEK1 protein differentially regulates, the Toll-like receptor 2 protein-dependent activation of human endothelial cells and monocytes

Sunadome, K.; Yamamoto, T.; Ebisuya, M.; Kondoh, K.; Sehara-Fujisawa, A.; Nishida, E., 2011:
ERK5 regulates muscle cell fusion through Klf transcription factors

Ananieva, O.; Macdonald, A.; Wang, X.; McCoy, C.E.; McIlrath, J.; Tournier, C.; Arthur, J.Simon.C., 2008:
ERK5 regulation in naïve T-cell activation and survival

Klein, A.M.; Cobb, M.H., 2014:
ERK5 signaling gets XIAPed: a role for ubiquitin in the disassembly of a MAPK cascade

Yue, B.; Ren, Q-X.; Su, T.; Wang, L-N.; Zhang, L., 2015:
ERK5 silencing inhibits invasion of human osteosarcoma cell via modulating the Slug/MMP-9 pathway

Arias-González, L.; Moreno-Gimeno, I.; del Campo, A.Rubio.; Serrano-Oviedo, L.; Valero, Mía.Llanos.; Esparís-Ogando, A.; de la Cruz-Morcillo, M.Ángel.; Melgar-Rojas, P.; García-Cano, Jús.; Cimas, F.José.; Hidalgo, Mía.José.Ruiz.; Prado, A.; Callejas-Valera, J.Luis.; Nam-Cha, S.Hyun.; Giménez-Bachs, Jé.Miguel.; Salinas-Sánchez, A.S.; Pandiella, A.; del Peso, L.; Sánchez-Prieto, R., 2014:
ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma

Su, C.; Sun, F.; Cunningham, R.L.; Rybalchenko, N.; Singh, M., 2015:
ERK5/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning

Goalstone, M.L., 2011:
ERK5: a novel IKKα-kinase in rat hippocampal neurons

Chia, J.; Tham, K.Min.; Gill, D.James.; Bard-Chapeau, E.Anne.; Bard, F.A., 2014:
ERK8 is a negative regulator of O-GalNAc glycosylation and cell migration

Lehtola, J.; Hakala, M.; Sakko, A.; Hämäläinen, K., 2012:
ERKALE-A flexible program package for X-ray properties of atoms and molecules

Verma, M.; Steer, E.K.; Chu, C.T., 2014:
ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease

Aggeli, I.K.S.; Beis, I.; Gaitanaki, C., 2010:
ERKs and JNKs mediate hydrogen peroxide-induced Egr-1 expression and nuclear accumulation in H9c2 cells

Wang, D.; Guo, T.Q.; Wang, Z.Y.; Lu, J.H.; Liu, D.P.; Meng, Q.F.; Xie, J.; Zhang, X.L.; Liu, Y.; Teng, L.S., 2015:
ERKs and mitochondria-related pathways are essential for glycyrrhizic acid-mediated neuroprotection against glutamate-induced toxicity in differentiated PC12 cells

Deschênes-Simard, X.; Kottakis, F.; Meloche, S.; Ferbeyre, G., 2014:
ERKs in cancer: friends or foes?

Liu, J.; Mao, W.; Ding, B.; Liang, C-seng., 2008:
ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes

Guo, X.; Wang, L.; Chen, B.; Li, Q.; Wang, J.; Zhao, M.; Wu, W.; Zhu, P.; Huang, X.; Huang, Q., 2009:
ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability

McClatchey, A.I., 2013:
ERM proteins

McClatchey, A.I., 2015:
ERM proteins at a glance

Darmellah, A.; Rücker-Martin, C.; Feuvray, D., 2009:
ERM proteins mediate the effects of Na+/H+ exchanger (NHE1) activation in cardiac myocytes

Mintz, C.David.; Carcea, I.; McNickle, D.G.; Dickson, T.C.; Ge, Y.; Salton, S.R.J.; Benson, D.L., 2008:
ERM proteins regulate growth cone responses to Sema3A

Ou-Yang, M.; Liu, H-Rui.; Zhang, Y.; Zhu, X.; Yang, Q., 2011:
ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells

Liu, D.; Songyang, Z., 2008:
ERM-mediated genetic screens in mammalian cells

de Sousa, V.Paiva.Leite.; Chaves, C.Bessa.Pereira.; Huguenin, J.Ferreira.Loureiro.; Moreira, Fábio.Carvalho.de.Barros.; de Reis, B.Souza.Bianchi.; Chimelli, L.; Bergmann, A.; Simão, T.de.Almeida.; Pinto, L.Felipe.Ribeiro., 2015:
ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression

Monge, M.; Colas, E.; Doll, A.; Gonzalez, M.; Gil-Moreno, A.; Planaguma, J.; Quiles, M.; Arbos, M.Antonia.; Garcia, A.; Castellvi, J.; Llaurado, M.; Rigau, M.; Alazzouzi, H.; Xercavins, J.; Alameda, F.; Reventos, J.; Abal, M., 2007:
ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer

Kornmann, Bît., 2010:
ERMES, a multifunctional complex connecting endoplasmic reticulum and mitochondria

Kornmann, Bît.; Walter, P., 2010:
ERMES-mediated ER-mitochondria contacts: molecular hubs for the regulation of mitochondrial biology

Paganelli, F.; Spinicci, E.; Giuli, D., 2008:
ERMHAN: A Context-Aware Service Platform to Support Continuous Care Networks for Home-Based Assistance

Nakano, R.Thomas.; Matsushima, R.; Nagano, A.J.; Fukao, Y.; Fujiwara, M.; Kondo, M.; Nishimura, M.; Hara-Nishimura, I., 2013:
ERMO3/MVP1/GOLD36 is involved in a cell type-specific mechanism for maintaining ER morphology in Arabidopsis thaliana

Pan, S.; Cheng, X.; Chen, H.; Castro, P.D.; Ittmann, M.M.; Hutson, A.W.; Zapata, S.K.; Sifers, R.N., 2014:
ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC)

Inzlicht, M.; Al-Khindi, T., 2013:
ERN and the placebo: a misattribution approach to studying the arousal properties of the error-related negativity

Anonymous, 1933:

Soranzo, N.; Altafini, C., 2010:
ERNEST: a toolbox for chemical reaction network theory

Khosrowabadi, R.; Quek, C.; Ang, K.Keng.; Wahab, A., 2015:
ERNN: a biologically inspired feedforward neural network to discriminate emotion from EEG signal

Zito, E.; Chin, K-Tung.; Blais, J.; Harding, H.P.; Ron, D., 2010:
ERO1-beta, a pancreas-specific disulfide oxidase, promotes insulin biogenesis and glucose homeostasis

Danion, M.; Le Floch, Séphane.; Lamour, Fçois.; Quentel, C., 2015:
EROD activity and antioxidant defenses of sea bass (Dicentrarchus labrax) after an in vivo chronic hydrocarbon pollution followed by a post-exposure period

Oliva, M.; Gravato, C.; Guilhermino, L.; Galindo-Riaño, Mía.Dolores.; Perales, Jé.Antonio., 2015:
EROD activity and cytochrome P4501A induction in liver and gills of Senegal sole Solea senegalensis from a polluted Huelva estuary (SW Spain)

da Silva Rocha, A.José.; Gomes, V.; Rocha Passos, M.José.de.Arruda.Campos.; Hasue, F.Matsu.; Alves Santos, Tís.Cruz.; Bícego, Márcia.Caruso.; Taniguchi, S.; Van Ngan, P., 2013:
EROD activity and genotoxicity in the seabob shrimp Xiphopenaeus kroyeri exposed to benzo[a]pyrene (BaP) concentrations

Velando, A.; Munilla, I.; López-Alonso, M.; Freire, J.; Pérez, C., 2010:
EROD activity and stable isotopes in seabirds to disentangle marine food web contamination after the Prestige oil spill

Nahrgang, J.; Jönsson, M.; Camus, L., 2010:
EROD activity in liver and gills of polar cod (Boreogadus saida) exposed to waterborne and dietary crude oil

Guiavarc'h, Y.P.; Chahin, A.; Dziurla, M-Antoinette.; Yen, F.T.; Jondreville, C.; Rychen, G., 2011:
EROD activity in peripheral blood lymphocytes and 1-hydroxypyrene in urine and milk as biomarkers of PAH exposure in dairy ruminants

Chahin, A.; Peiffer, J.; Olry, J-Charles.; Crepeaux, G.; Schroeder, H.; Rychen, G.; Guiavarc'h, Y., 2014:
EROD activity induction in peripheral blood lymphocytes, liver and brain tissues of rats orally exposed to polycyclic aromatic hydrocarbons

Zamaratskaia, G.; Zlabek, V., 2009:
EROD and MROD as Markers of Cytochrome P450 1A Activities in Hepatic Microsomes from Entire and Castrated Male Pigs

Burón, E.; Bulbena, A.; Barrada, J.R.; Pailhez, G., 2014:
EROL scale: a new behavioural olfactory measure and its relationship with anxiety and depression symptoms

Palmer, D.; El Miedany, Y., 2010:
EROMIA in inflammatory arthritis: the next step in standard practice

Glanz, J., 1995:
EROS, MACHO, And OGLE Net A Haul of Data

Yang, S.; Roux, Bît., 2011:
EROS: Better than SAXS!

Holcomb, P.J.; Grainger, J., 2010:
ERP Effects of Short Interval Masked Associative and Repetition Priming

Czernochowski, D., 2011:
ERP Evidence for Scarce Rule Representation in Older Adults Following Short, but Not Long Preparatory Intervals

Dell'acqua, R.; Sessa, P.; Peressotti, F.; Mulatti, C.; Navarrete, E.; Grainger, J., 2010:
ERP Evidence for Ultra-Fast Semantic Processing in the Picture-Word Interference Paradigm

Akshoomoff, N.A.; Courchesne, E., 1994:
ERP Evidence for a Shifting Attention Deficit in Patients with Damage to the Cerebellum

Demestre, J.; García-Albea, Jé.E., 2007:
ERP Evidence for the Rapid Assignment of an (Appropriate) Antecedent to PRO

Kaan, E.; Carlisle, E., 2014:
ERP Indices of Stimulus Prediction in Letter Sequences

Janata, P., 1995:
ERP Measures Assay the Degree of Expectancy Violation of Harmonic Contexts in Music

Yang, J-Chen.; Chi, L.; Teichholtz, S.; Schneider, A.; Nanakul, R.; Nowacki, R.; Seritan, A.; Reed, B.; DeCarli, C.; Iragui, V.J.; Kutas, M.; Hagerman, P.J.; Hagerman, R.J.; Olichney, J.M., 2015:
ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI

Möhring, N.; Brandt, E.S.L.; Mohr, B.; Pulvermüller, F.; Neuhaus, A.H., 2015:
ERP adaptation provides direct evidence for early mirror neuron activation in the inferior parietal lobule

Fein, G.; Key, K.; Szymanski, M.D., 2011:
ERP and RT delays in long-term abstinent alcoholics in processing of emotional facial expressions during gender and emotion categorization tasks

Bergström, Z.M.; de Fockert, J.W.; Richardson-Klavehn, A., 2009:
ERP and behavioural evidence for direct suppression of unwanted memories

Kamp, S-Maria.; Donchin, E., 2016:
ERP and pupil responses to deviance in an oddball paradigm

Ahiskali, M.; Green, D.; Kounios, J.; Clark, C.M.; Polikar, R., 2010:
ERP based decision fusion for AD diagnosis across cohorts

Martin, C.D.; Thierry, G.; Démonet, J-François., 2011:
ERP characterization of sustained attention effects in visual lexical categorization

Xiao, S.; Cai, B.; Jiang, L.; Wang, Y.; Chen, W.; Zheng, X., 2015:
ERP component analysis for rapid image searching in finer categories

Zordan, L.; Sarlo, M.; Stablum, F., 2007:
ERP components activated by the "GO!" and "WITHHOLD!" conflict in the random Sustained Attention to Response Task

Hänel-Faulhaber, B.; Skotara, N.; Kügow, M.; Salden, U.; Bottari, D.; Röder, B., 2014:
ERP correlates of German Sign Language processing in deaf native signers

Hughes, G.; Waszak, F., 2011:
ERP correlates of action effect prediction and visual sensory attenuation in voluntary action

Grasso, D.J.; Moser, J.S.; Dozier, M.; Simons, R., 2009:
ERP correlates of attention allocation in mothers processing faces of their children

Korzyukov, O.; Karvelis, L.; Behroozmand, R.; Larson, C.R., 2012:
ERP correlates of auditory processing during automatic correction of unexpected perturbations in voice auditory feedback

Mennes, M.; Wouters, H.; van den Bergh, B.; Lagae, L.; Stiers, P., 2008:
ERP correlates of complex human decision making in a gambling paradigm: detection and resolution of conflict

Wiersema, J.R.; Roeyers, H., 2008:
ERP correlates of effortful control in children with varying levels of ADHD symptoms

Wiersema, J.R.; van der Meere, J.J.; Roeyers, H., 2009:
ERP correlates of error monitoring in adult ADHD

Vergara-Martínez, M.; Duñabeitia, J.Andoni.; Laka, I.; Carreiras, M., 2009:
ERP correlates of inhibitory and facilitative effects of constituent frequency in compound word reading

Mecklinger, A.; Parra, M.; Waldhauser, G.T., 2009:
ERP correlates of intentional forgetting

Wolk, D.A.; Sen, N.Mandu.; Chong, H.; Riis, J.L.; McGinnis, S.M.; Holcomb, P.J.; Daffner, K.R., 2008:
ERP correlates of item recognition memory: effects of age and performance

Vergara-Martínez, M.; Perea, M.; Gómez, P.; Swaab, T.Y., 2013:
ERP correlates of letter identity and letter position are modulated by lexical frequency

Kirsch, W.; Hennighausen, E.; Rösler, F., 2010:
ERP correlates of linear hand movements in a motor reproduction task

Kirsch, W.; Hennighausen, E., 2010:
ERP correlates of linear hand movements: distance dependent changes

Hoover, S.; Zottoli, T.M.; Grose-Fifer, J., 2014:
ERP correlates of malingered executive dysfunction

Tan, A.A.; Molfese, D.L., 2008:
ERP correlates of noun and verb processing in preschool-age children

Hawco, C.S.; Jones, J.A.; Ferretti, T.R.; Keough, D., 2010:
ERP correlates of online monitoring of auditory feedback during vocalization

Schreiber, M.; Pietschmann, M.; Kathmann, N.; Endrass, T., 2011:
ERP correlates of performance monitoring in elderly

Behroozmand, R.; Korzyukov, O.; Larson, C.R., 2012:
ERP correlates of pitch error detection in complex tone and voice auditory feedback with missing fundamental

Tsang, Y-Kei.; Jia, S.; Huang, J.; Chen, H-Chih., 2011:
ERP correlates of pre-attentive processing of Cantonese lexical tones: The effects of pitch contour and pitch height

Friedrich, M.; Herold, B.; Friederici, A.D., 2009:
ERP correlates of processing native and non-native language word stress in infants with different language outcomes

Massand, E.; Bowler, D.M.; Mottron, L.; Hosein, A.; Jemel, B., 2014:
ERP correlates of recognition memory in Autism Spectrum Disorder

Upton, D.J.; Enticott, P.G.; Croft, R.J.; Cooper, N.R.; Fitzgerald, P.B., 2011:
ERP correlates of response inhibition after-effects in the stop signal task

Baetens, K.; Van der Cruyssen, L.; Vandekerckhove, M.; Van Overwalle, F., 2015:
ERP correlates of script chronology violations

Gomarus, H.Karin.; Wijers, A.A.; Minderaa, R.B.; Althaus, M., 2008 :
ERP correlates of selective attention and working memory capacities in children with ADHD and/or PDD-NOS

Diana, R.A.; Van den Boom, W.; Yonelinas, A.P.; Ranganath, C., 2011:
ERP correlates of source memory: unitized source information increases familiarity-based retrieval

Demiral, Sükrü.Barış.; Malcolm, G.L.; Henderson, J.M., 2012:
ERP correlates of spatially incongruent object identification during scene viewing: contextual expectancy versus simultaneous processing

Schumacher, R.; Wirth, M.; Perrig, W.J.; Strik, W.; Koenig, T., 2009:
ERP correlates of superordinate category activation

Forster, B.; Sambo, C.F.; Pavone, E.F., 2009:
ERP correlates of tactile spatial attention differ under intra- and intermodal conditions

Treese, A-Cécile.; Johansson, M.; Lindgren, M., 2010:
ERP correlates of target-distracter differentiation in repeated runs of a continuous recognition task with emotional and neutral faces

Meng, X.; Jian, J.; Shu, H.; Tian, X.; Zhou, X., 2008:
ERP correlates of the development of orthographical and phonological processing during Chinese sentence reading

Jaeger, A.; Johnson, J.D.; Corona, M.; Rugg, M.D., 2009:
ERP correlates of the incidental retrieval of emotional information: effects of study-test delay

Bell, R.; Dentale, S.; Buchner, A.; Mayr, S., 2011:
ERP correlates of the irrelevant sound effect

Becker, A.B.C.; Schild, U.; Friedrich, C.K., 2015:
ERP correlates of word onset priming in infants and young children

Laganaro, M.; Morand, Séphanie.; Michel, C.M.; Spinelli, L.; Schnider, A., 2011:
ERP correlates of word production before and after stroke in an aphasic patient

Ivannikov, A.; Kalyakin, I.; Hämäläinen, J.; Leppänen, P.H.T.; Ristaniemi, T.; Lyytinen, H.; Kärkkäinen, T., 2009:
ERP denoising in multichannel EEG data using contrasts between signal and noise subspaces

Kong, F.; Zhang, Y.; Chen, H., 2013:
ERP differences between processing of physical characteristics and personality attributes

Kast, M.; Elmer, S.; Jancke, L.; Meyer, M., 2011:
ERP differences of pre-lexical processing between dyslexic and non-dyslexic children

Busch, N.A.; Dürschmid, S.; Herrmann, C.S., 2010:
ERP effects of change localization, change identification, and change blindness

Kotz, S.A.; Opitz, B.; Friederici, A.D., 2007:
ERP effects of meaningful and non-meaningful sound processing in anterior temporal patients

Studer, P.; Wangler, S.; Diruf, M.S.; Kratz, O.; Moll, G.H.; Heinrich, H., 2010:
ERP effects of methylphenidate and working memory load in healthy adults during a serial visual working memory task

Ikeda, K.; Hashimoto, S.; Hayashi, A.; Kanno, A., 2009:
ERP evaluation of auditory sensory memory systems in adults with intellectual disability

Morel, S.; George, N.; Foucher, Aélie.; Chammat, M.; Dubal, Séphanie., 2014:
ERP evidence for an early emotional bias towards happy faces in trait anxiety

Lai, V.Tzuyin.; Curran, T., 2014:
ERP evidence for conceptual mappings and comparison processes during the comprehension of conventional and novel metaphors

Mudrik, L.; Lamy, D.; Deouell, L.Y., 2010:
ERP evidence for context congruity effects during simultaneous object-scene processing

Qu, Z.; Song, Y.; Ding, Y., 2010:
ERP evidence for distinct mechanisms of fast and slow visual perceptual learning

Ecker, U.K.H.; Zimmer, H.D., 2008:
ERP evidence for flexible adjustment of retrieval orientation and its influence on familiarity

Hall, S.S.; Pollux, P.M.J.; Roebuck, H.; Guo, K., 2014:
ERP evidence for human early visual sensitivity to co-linearity compared to co-circularity

Handy, T.C.; Smilek, D.; Geiger, L.; Liu, C.; Schooler, J.W., 2010:
ERP evidence for rapid hedonic evaluation of logos

Luo, Y.; Zhou, X., 2010:
ERP evidence for the online processing of rhythmic pattern during Chinese sentence reading

Hu, W.; Lu, Y.; Ren, C.; Zhang, J.X., 2014:
ERP evidence for the time course of mental rotation in the mirror reading of Chinese words

Beaucousin, V.; Cassotti, M.; Simon, Gégory.; Pineau, A.; Kostova, M.; Houdé, O.; Poirel, N., 2011:
ERP evidence of a meaningfulness impact on visual global/local processing: when meaning captures attention

Padrão, Gçalo.; Penhune, V.; de Diego-Balaguer, R.; Marco-Pallares, J.; Rodriguez-Fornells, A., 2015 :
ERP evidence of adaptive changes in error processing and attentional control during rhythm synchronization learning

Bomba, M.D.; Singhal, A., 2011:
ERP evidence of early cross-modal links between auditory selective attention and visuo-spatial memory

Nemrodov, D.; Harpaz, Y.; Javitt, D.C.; Lavidor, M., 2011:
ERP evidence of hemispheric independence in visual word recognition

Lavric, A.; Clapp, A.; Rastle, K., 2007:
ERP evidence of morphological analysis from orthography: a masked priming study

Page, J.W.; Duhamel, P.; Crognale, M.A., 2011:
ERP evidence of visualization at early stages of visual processing

Frtusova, J.B.; Winneke, A.H.; Phillips, N.A., 2014:
ERP evidence that auditory-visual speech facilitates working memory in younger and older adults

Khoe, W.; Mitchell, J.F.; Reynolds, J.H.; Hillyard, S.A., 2008:
ERP evidence that surface-based attention biases interocular competition during rivalry

Bobes, Mía.A.; García, Y.Fernández.; Lopera, F.; Quiroz, Y.T.; Galán, Lídice.; Vega, M.; Trujillo, N.; Valdes-Sosa, M.; Valdes-Sosa, P., 2010:
ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280A PS-1 mutation

Kayser, Jürgen.; Tenke, C.E.; Gil, R.; Bruder, G.E., 2010:
ERP generator patterns in schizophrenia during tonal and phonetic oddball tasks: effects of response hand and silent count

Coleman, M.R., 2012:
ERP grants first action status to candidate tissue residue methods for high-priority animal drugs

Anonymous, 2010:
ERP implementation services. In an environment of smaller projects requiring specialized skills sets, a few consulting firms have adapted and excelled

Sehlmeyer, C.; Konrad, C.; Zwitserlood, P.; Arolt, V.; Falkenstein, M.; Beste, C., 2010:
ERP indices for response inhibition are related to anxiety-related personality traits

Keage, H.A.D.; Clark, C.Richard.; Hermens, D.F.; Williams, L.M.; Kohn, M.R.; Clarke, S.; Lamb, C.; Crewther, D.; Gordon, E., 2008:
ERP indices of working memory updating in AD/HD: differential aspects of development, subtype, and medication

Forster, B.; Gillmeister, H., 2011:
ERP investigation of transient attentional selection of single and multiple locations within touch

Finnigan, S.; O'Connell, R.G.; Cummins, T.D.R.; Broughton, M.; Robertson, I.H., 2011:
ERP measures indicate both attention and working memory encoding decrements in aging

Frishkoff, G.A.; Perfetti, C.A.; Westbury, C., 2008:
ERP measures of partial semantic knowledge: left temporal indices of skill differences and lexical quality

Taler, V.; Kousaie, S.; López Zunini, Río., 2013:
ERP measures of semantic richness: the case of multiple senses

Wright, M.J.; Geffen, G.M.; Geffen, L.B., 1996:
ERP measures of stimulus processing during an auditory oddball task in Parkinson's disease: Evidence for an early information processing deficit

Craig, D.; Carli, F., 2018:
Bromage motor blockade score - a score that has lasted more than a lifetime

Nie, A.; Griffin, M.; Keinath, A.; Walsh, M.; Dittmann, A.; Reder, L., 2014:
ERP profiles for face and word recognition are based on their status in semantic memory not their stimulus category

Webb, S.Jane.; Merkle, K.; Murias, M.; Richards, T.; Aylward, E.; Dawson, G., 2012:
ERP responses differentiate inverted but not upright face processing in adults with ASD

Demorest, S.M.; Osterhout, L., 2012:
ERP responses to cross-cultural melodic expectancy violations

Key, A.P.; Corbett, B.A., 2014:
ERP responses to face repetition during passive viewing: a nonverbal measure of social motivation in children with autism and typical development

Wang, L.; Bastiaansen, M.; Yang, Y., 2015:
ERP responses to person names as a measure of trait inference in person perception

Scharinger, M.; Felder, V., 2012:
ERP signatures of cross-modal semantic fragment priming: early context effects in speech perception

Wang, L.; Yao, D., 2010:
ERP spatio-temporal analysis for perception of motion-in-depth: the effect of size factor on cognition

Miyakoshi, M.; Kanayama, N.; Nomura, M.; Iidaka, T.; Ohira, H., 2008:
ERP study of viewpoint-independence in familiar-face recognition

Van der Cruyssen, L.; Van Duynslaeger, M.; Cortoos, A.; Van Overwalle, F., 2009:
ERP time course and brain areas of spontaneous and intentional goal inferences

Laganaro, M., 2014 :
ERP topographic analyses from concept to articulation in word production studies

Lopez-Calderon, J.; Luck, S.J., 2014:
ERPLAB: an open-source toolbox for the analysis of event-related potentials

Mongé, M.C.; Eltayeb, O.M.; Costello, J.M.; Johnson, J.T.; Popescu, A.R.; Rigsby, C.K.; Backer, C.L., 2018:
Brom Aortoplasty for Supravalvular Aortic Stenosis

Depue, B.Eliot.; Ketz, N.; Mollison, M.V.; Nyhus, E.; Banich, M.T.; Curran, T., 2014:
ERPs and neural oscillations during volitional suppression of memory retrieval

Lawrence, C.A.; Barry, R.J., 2010:
ERPs and the evoked cardiac response to auditory stimuli: Intensity and cognitive load effects

van Meel, C.S.; Heslenfeld, D.J.; Oosterlaan, J.; Luman, M.; Sergeant, J.A., 2011:
ERPs associated with monitoring and evaluation of monetary reward and punishment in children with ADHD

Czernochowski, D., 2015:
ERPs dissociate proactive and reactive control: evidence from a task-switching paradigm with informative and uninformative cues

Gontier, E.; Paul, I.; Le Dantec, C.; Pouthas, V.; Jean-Marie, G.; Bernard, C.; Lalonde, R.; Rebaï, M., 2009:
ERPs in anterior and posterior regions associated with duration and size discriminations

Carlson, S.R.; Thái, S., 2011:
ERPs on a continuous performance task and self-reported psychopathic traits: P3 and CNV augmentation are associated with Fearless Dominance

Batterink, L.; Neville, H.J., 2015:
ERPs recorded during early second language exposure predict syntactic learning

Epstein, B.; Hestvik, A.; Shafer, V.L.; Schwartz, R.G., 2014:
ERPs reveal atypical processing of subject versus object Wh-questions in children with specific language impairment

Kotz, S.A.; Holcomb, P.J.; Osterhout, L., 2007:
ERPs reveal comparable syntactic sentence processing in native and non-native readers of English

Tanner, D.; Van Hell, J.G., 2014:
ERPs reveal individual differences in morphosyntactic processing

Dwivedi, V.D.; Drury, J.E.; Molnar, M.; Phillips, N.A.; Baum, S.; Steinhauer, K., 2010:
ERPs reveal sensitivity to hypothetical contexts in spoken discourse

Wu, Y.; Mo, D.; Tsang, Y-Kei.; Chen, H-Chih., 2012:
ERPs reveal sub-lexical processing in Chinese character recognition

Nickels, S.; Opitz, B.; Steinhauer, K., 2014:
ERPs show that classroom-instructed late second language learners rely on the same prosodic cues in syntactic parsing as native speakers

Ibáñez, Aín.M.; Martín, Ré.San.; Hurtado, E.; López, V., 2012:
ERPs studies of cognitive processing during sleep

Brown, C.R.; Barry, R.J.; Clarke, A.R., 2009:
ERPs to infrequent auditory stimuli in two- and three-stimulus versions of the inter-modal oddball task

Buchberger, A., 2014:
ERQC autophagy: Yet another way to die

Gallet, Mène.; Vanacker, J-Marc., 2011:
ERR receptors as potential targets in osteoporosis

Lai, C-Yu.; Lv, P-Long.; Dong, Q-Yi.; Yeo, S.Lei.; Rittmann, B.E.; Zhao, H-Ping., 2018:
Bromate and Nitrate Bioreduction Coupled with Poly-β-hydroxybutyrate Production in a Methane-Based Membrane Biofilm Reactor

Yang, Y.; Ding, Q.; Wen, D.; Yang, M.; Wang, Y.; Liu, N.; Zhang, X., 2018:
Bromate removal from aqueous solution with novel flower-like Mg-Al-layered double hydroxides

Hatano, K-Ichi.; Takahashi, K.; Tanokura, M., 2018:
Bromein, a Bromelain Inhibitor from Pineapple Stem: Structural and Functional Characteristics

Rajalin, A-Marie.; Pollock, H.; Aarnisalo, P., 2010:
ERRalpha regulates osteoblastic and adipogenic differentiation of mouse bone marrow mesenchymal stem cells

Zhou, W.; Lo, S-Ching.; Liu, J-Hua.; Hannink, M.; Lubahn, D.B., 2007:
ERRbeta: a potent inhibitor of Nrf2 transcriptional activity

Alaynick, W.A.; Kondo, R.P.; Xie, W.; He, W.; Dufour, C.R.; Downes, M.; Jonker, J.W.; Giles, W.; Naviaux, R.K.; Giguère, V.; Evans, R.M., 2007:
ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart

Riggins, R.B.; Lan, J.P-J.; Zhu, Y.; Klimach, U.; Zwart, A.; Cavalli, L.R.; Haddad, B.R.; Chen, L.; Gong, T.; Xuan, J.; Ethier, S.P.; Clarke, R., 2008:
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer

Alaynick, W.A.; Way, J.M.; Wilson, S.A.; Benson, W.G.; Pei, L.; Downes, M.; Yu, R.; Jonker, J.W.; Holt, J.A.; Rajpal, D.K.; Li, H.; Stuart, J.; McPherson, R.; Remlinger, K.S.; Chang, C-Yi.; McDonnell, D.P.; Evans, R.M.; Billin, A.N., 2010:
ERRgamma regulates cardiac, gastric, and renal potassium homeostasis

Matsushima, A.; Teramoto, T.; Okada, H.; Liu, X.; Tokunaga, T.; Kakuta, Y.; Shimohigashi, Y., 2008:
ERRgamma tethers strongly bisphenol A and 4-alpha-cumylphenol in an induced-fit manner

Bianco, Séphanie.; Sailland, J.; Vanacker, J-Marc., 2012:
ERRs and cancers: effects on metabolism and on proliferation and migration capacities

Zou, C.; Yu, S.; Xu, Z.; Wu, D.; Ng, C-Fai.; Yao, X.; Yew, D.T.; Vanacker, J-Marc.; Chan, F.L., 2014:
ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells

Bernatchez, Gérald.; Giroux, Véronique.; Lassalle, T.; Carpentier, Aé.C.; Rivard, N.; Carrier, J.C., 2013:
ERRα metabolic nuclear receptor controls growth of colon cancer cells

Cardelli, M.; Aubin, J.E., 2015:
ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice

Bonsignore, M.R.; Eckel, J., 2011:
ERS Meeting Report. Metabolic aspects of obstructive sleep apnoea syndrome

Nicod, L.P.; Kamel, N.; Ward, B.; Decramer, M.; Sibille, Y.; Lambrecht, B.; Dive, C.; Smith, U.; Sipido, K.R., 2011:
ERS is founding member of a new Alliance for Biomedical Research in Europe

Sigsgaard, T.; Nowak, D.; Annesi-Maesano, I.; Nemery, B.; Torén, K.; Viegi, G.; Radon, K.; Burge, S.; Heederik, D., 2010:
ERS position paper: work-related respiratory diseases in the EU

Clery, D., 1993:
ERS-1 Gives Europeans New Views of the Oceans

Brunelli, A.; Charloux, A.; Bolliger, C.T.; Rocco, G.; Sculier, J-P.; Varela, G.; Licker, M.; Ferguson, M.K.; Faivre-Finn, C.; Huber, R.M.; Clini, E.M.; Win, T.; De Ruysscher, D.; Goldman, L., 2009:
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)

Esposito, S.; D'Ambrosio, L.; Tadolini, M.; Schaaf, H.Simon.; Caminero Luna, Jè.; Marais, B.; Centis, R.; Dara, M.; Matteelli, A.; Blasi, F.; Migliori, G.Battista., 2015:
ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use

D'Ambrosio, L.; Tadolini, M.; Dupasquier, S.; Tiberi, S.; Centis, R.; Dara, M.; Blasi, F.; Migliori, G.Battista., 2014:
ERS/WHO tuberculosis consilium: reporting of the initial 10 cases

Lukens, J.E., 1969:
ERS: Can the Cost Be Measured?

Anonymous, 1948:
ERSATZ glycerol

Schröder, F.H.; Roobol, M.J., 2011:
ERSPC and PLCO prostate cancer screening studies: what are the differences?

Schröder, F.H., 2014:
ERSPC, PLCO studies and critique of cochrane review 2013

Maugh, T.H., 1973:
ERTS (II): A New Way of Viewing the Earth

Anderson, J.H., 1973:
ERTS Imagery

Shapley, D., 1975:
ERTS: Americans Took Pictures of Soviet Union--To Be Friendly

Shapley, D., 1974:
ERTS: Fight over a Third Satellite Looms

Maugh, T.H., 1973:
ERTS: Surveying Earth's Resources from Space

Gault, W.A.; Brown, S.; Moise, A.; Liang, D.; Sellar, G.; Shepherd, G.G.; Wimperis, J., 1996:
ERWIN: an E-region wind interferometer

Alderson, H.E.; Coe, H.C., 1924:
ERYTHEMA INDURATUM: Report of a case treated with tuberculin and the Kromayer Lamp

Anonymous, 2014:
ERYTHROCIN in trachoma

Anonymous, 2014:
ERYTHROMYCIN prophylaxis against ophthalmia neonatorum

Anonymous, 2014:
ERYTHROMYCIN; a current appraisal

Anonymous, 2014:
ERYTHROMYCIN; a new antibiotic

Maniatis, G.M.; Ingram, V.M., 1971:
ERYTHROPOIESIS DURING AMPHIBIAN METAMORPHOSIS : I. Site of Maturation of Erythrocytes in Rana catesbeiana

Maniatis, G.M.; Ingram, V.M., 1971:
ERYTHROPOIESIS DURING AMPHIBIAN METAMORPHOSIS : II. Immunochemical Study of Larval and Adult Hemoglobins of Rana catesbeiana

Maniatis, G.M.; Ingram, V.M., 1971:
ERYTHROPOIESIS DURING AMPHIBIAN METAMORPHOSIS : III. Immunochemical Detection of Tadpole and Frog Hemoglobins (Rana catesbeiana) in Single Erythrocytes

Lambertini, E.; Tavanti, E.; Torreggiani, E.; Penolazzi, L.; Gambari, R.; Piva, R., 2008:
ERalpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ERalpha gene in osteoblasts

Cardamone, M.Dafne.; Bardella, C.; Gutierrez, A.; Di Croce, L.; Rosenfeld, M.G.; Di Renzo, M.Flavia.; De Bortoli, M., 2009:
ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells

Colitz, C.M.H.; Sugimoto, Y.; Lu, P.; Barden, C.Andrew.; Thomas-Ahner, J.; Chandler, H.Lynn., 2009:
ERalpha increases expression and interacts with TERT in cataractous canine lens epithelial cells

Ye, Y.; Xiao, Y.; Wang, W.; Yearsley, K.; Gao, J-Xin.; Barsky, S.H., 2008:
ERalpha suppresses slug expression directly by transcriptional repression

Meyer, M.R.; Barton, M., 2009:
ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis

Mazzucco, C.A.; Walker, H.A.; Pawluski, J.L.; Lieblich, S.E.; Galea, L.A.M., 2008:
ERalpha, but not ERbeta, mediates the expression of sexual behavior in the female rat

Chen, J-Qiang.; Russo, J., 2009:
ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches

Fehm, T.; Krawczyk, N.; Solomayer, E-Franz.; Becker-Pergola, G.; Dürr-Störzer, S.; Neubauer, H.; Seeger, H.; Staebler, A.; Wallwiener, D.; Becker, S., 2008:
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients

Kubota, E.; Kataoka, H.; Tanaka, M.; Okamoto, Y.; Ebi, M.; Hirata, Y.; Murakami, K.; Mizoshita, T.; Shimura, T.; Mori, Y.; Tanida, S.; Kamiya, T.; Aoyama, M.; Asai, K.; Joh, T., 2011:
ERas enhances resistance to CPT-11 in gastric cancer

Tanaka, Y.; Ikeda, T.; Kishi, Y.; Masuda, S.; Shibata, H.; Takeuchi, K.; Komura, M.; Iwanaka, T.; Muramatsu, S-Ichi.; Kondo, Y.; Takahashi, K.; Yamanaka, S.; Hanazono, Y., 2009:
ERas is expressed in primate embryonic stem cells but not related to tumorigenesis

Yasuda, K.; Yashiro, M.; Sawada, T.; Ohira, M.; Hirakawa, K., 2008:
ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells

Mak, P.; Leav, I.; Pursell, B.; Bae, D.; Yang, X.; Taglienti, C.A.; Gouvin, L.M.; Sharma, V.M.; Mercurio, A.M., 2010:
ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading

Fan, X.; Xu, H.; Warner, M.; Gustafsson, J-Ake., 2010:
ERbeta in CNS: new roles in development and function

Fox, E.M.; Davis, R.J.; Shupnik, M.A., 2008:
ERbeta in breast cancer--onlooker, passive player, or active protector?

Vu, A.T.; Campbell, A.N.; Harris, H.A.; Unwalla, R.J.; Manas, E.S.; Mewshaw, R.E., 2007:
ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands

Thomas, C.; Rajapaksa, G.; Nikolos, F.; Hao, R.; Katchy, A.; McCollum, C.W.; Bondesson, M.; Quinlan, P.; Thompson, A.; Krishnamurthy, S.; Esteva, F.J.; Gustafsson, J-Åke., 2015:
ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR

Nilsson, S.; Kuiper, G.; Gustafsson, J.A., 2008:
ERbeta: a novel estrogen receptor offers the potential for new drug development

Sugiyama, N.; Barros, R.P.A.; Warner, M.; Gustafsson, J-Ake., 2010:
ERbeta: recent understanding of estrogen signaling

Tan, Y.Lei.; Genereux, J.C.; Pankow, S.; Aerts, J.M.F.G.; Yates, J.R.; Kelly, J.W., 2015:
ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease

Jin, Y.; Zhuang, M.; Hendershot, L.M., 2009:
ERdj3, a luminal ER DnaJ homologue, binds directly to unfolded proteins in the mammalian ER: identification of critical residues

Dong, M.; Bridges, J.P.; Apsley, K.; Xu, Y.; Weaver, T.E., 2008:
ERdj4 and ERdj5 are required for endoplasmic reticulum-associated protein degradation of misfolded surfactant protein C

Lai, C.Walter.; Otero, J.H.; Hendershot, L.M.; Snapp, E., 2012:
ERdj4 protein is a soluble endoplasmic reticulum (ER) DnaJ family protein that interacts with ER-associated degradation machinery

Thomas, C.G.; Spyrou, G., 2009:
ERdj5 sensitizes neuroblastoma cells to endoplasmic reticulum stress-induced apoptosis

Jeong, W.; Lee, D-Yeon.; Park, S.; Rhee, S.Goo., 2008:
ERp16, an endoplasmic reticulum-resident thiol-disulfide oxidoreductase: biochemical properties and role in apoptosis induced by endoplasmic reticulum stress

Hirsch, I.; Weiwad, M.; Prell, E.; Ferrari, D.Michael., 2014:
ERp29 deficiency affects sensitivity to apoptosis via impairment of the ATF6-CHOP pathway of stress response

Zhang, B.; Wang, M.; Yang, Y.; Wang, Y.; Pang, X.; Su, Y.; Wang, J.; Ai, G.; Zou, Z., 2008:
ERp29 is a radiation-responsive gene in IEC-6 cell

Suaud, L.; Miller, K.; Alvey, L.; Yan, W.; Robay, A.; Kebler, C.; Kreindler, J.L.; Guttentag, S.; Hubbard, M.J.; Rubenstein, R.C., 2011:
ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells

Grumbach, Y.; Bikard, Y.; Suaud, L.; Chanoux, R.A.; Rubenstein, R.C., 2015:
ERp29 regulates epithelial sodium channel functional expression by promoting channel cleavage

Farmaki, E.; Mkrtchian, S.; Papazian, I.; Papavassiliou, A.G.; Kiaris, H., 2011:
ERp29 regulates response to doxorubicin by a PERK-mediated mechanism

Das, S.; Smith, T.D.; Sarma, J.Das.; Ritzenthaler, J.D.; Maza, J.; Kaplan, B.E.; Cunningham, L.A.; Suaud, L.; Hubbard, M.J.; Rubenstein, R.C.; Koval, M., 2009:
ERp29 restricts Connexin43 oligomerization in the endoplasmic reticulum

Helms, M.N.; Trac, P., 2015:
ERp29, a chaperone protein ushering in new insights on ion transport regulation. Focus on "ERp29 regulates epithelial sodium channel functional expression by promoting channel cleavage"

Pan, C.; Zheng, J.; Wu, Y.; Chen, Y.; Wang, L.; Zhou, Z.; Yin, W.; Ji, G., 2012:
ERp44 C160S/C212S mutants regulate IP3R1 channel activity

Cortini, M.; Sitia, R., 2010:
ERp44 and ERGIC-53 synergize in coupling efficiency and fidelity of IgM polymerization and secretion

Charlton, H.K.; Webster, J.; Kruger, S.; Simpson, F.; Richards, A.A.; Whitehead, J.P., 2010:
ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling

Alberti, A.; Karamessinis, P.; Peroulis, M.; Kypreou, K.; Kavvadas, P.; Pagakis, S.; Politis, P.K.; Charonis, A., 2009:
ERp46 is reduced by high glucose and regulates insulin content in pancreatic beta-cells

Zhang, Y.; Kozlov, G.; Pocanschi, C.L.; Brockmeier, U.; Ireland, B.S.; Maattanen, P.; Howe, C.; Elliott, T.; Gehring, K.; Williams, D.B., 2009:
ERp57 does not require interactions with calnexin and calreticulin to promote assembly of class I histocompatibility molecules, and it enhances peptide loading independently of its redox activity

Wang, H.; Chan, P-Kei.; Pan, S-Yuan.; Kwon, K-Ho.; Ye, Y.; Chu, J-Hong.; Fong, W-Fun.; Tsui, W.M.S.; Yu, Z-Ling., 2010:
ERp57 is up-regulated in free fatty acids-induced steatotic L-02 cells and human nonalcoholic fatty livers

Coe, H.; Jung, J.; Groenendyk, J.; Prins, D.; Michalak, M., 2010:
ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum

He, J.; Shi, W.; Guo, Y.; Chai, Z., 2014:
ERp57 modulates mitochondrial calcium uptake through the MCU

Coe, H.; Michalak, M., 2010:
ERp57, a multifunctional endoplasmic reticulum resident oxidoreductase

Ozaki, T.; Yamashita, T.; Ishiguro, S-Ichi., 2008:
ERp57-associated mitochondrial μ-calpain truncates apoptosis-inducing factor

Aureli, C.; Gaucci, E.; Arcangeli, V.; Grillo, C.; Eufemi, M.; Chichiarelli, S., 2013:
ERp57/PDIA3 binds specific DNA fragments in a melanoma cell line

Lubell, J., 2009:
ERs in distress: ACEP. Report cites states for not enough support, resources

Mohamed, S.Abu.Alkhair.; Atta, I.Shafek.; Rowan, B.G.; Desouki, M.Mokhtar., 2014:
ERα and ERK1/2 MAP kinase expression in microdissected stromal and epithelial endometrial cells

Kanczuga-Koda, L.; Koda, M.; Tomaszewski, J.; Jarzabek, K.; Lotowska, J.; Baltaziak, M.; Sulkowska, U.; Sobaniec-Lotowska, M.; Sulkowski, Sław., 2010:
ERα and ERβ expression in correlation with Ki-67, Bcl-2 and Bak in primary tumors and lymph node metastases of breast cancer: The effect of pre-operative chemotherapy

Shi, J-Feng.; Yang, N.; Ding, H-Jian.; Zhang, J-Xin.; Hu, M-Ling.; Leng, Y.; Han, X.; Sun, Y-Jie., 2015:
ERα directly activated the MDR1 transcription to increase paclitaxel-resistance of ERα-positive breast cancer cells in vitro and in vivo

Zhang, Q.; Jin, J.; Zhong, Q.; Yu, X.; Levy, D.; Zhong, S., 2013:
ERα mediates alcohol-induced deregulation of Pol III genes in breast cancer cells

Luft, F.C., 2014:
ERα on the cell membrane helps the heart

Lin, S.; Lin, C-Ju.; Hsieh, D.P.H.; Li, L-Ann., 2012:
ERα phenotype, estrogen level, and benzo[a]pyrene exposure modulate tumor growth and metabolism of lung adenocarcinoma cells

Sun, J.; Zhou, W.; Kaliappan, K.; Nawaz, Z.; Slingerland, J.M., 2013:
ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression

Vekariya, K.K.; Kaur, J.; Tikoo, K., 2013:
ERα signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer

Kim, M.; Neinast, M.D.; Frank, A.P.; Sun, K.; Park, J.; Zehr, J.A.; Vishvanath, L.; Morselli, E.; Amelotte, M.; Palmer, B.F.; Gupta, R.K.; Scherer, P.E.; Clegg, D.J., 2014:
ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue

Schultz-Norton, J.R.; Ziegler, Y.S.; Nardulli, A.M., 2011:
ERα-associated protein networks

Miller, T.W.; Balko, J.M.; Fox, E.M.; Ghazoui, Z.; Dunbier, A.; Anderson, H.; Dowsett, M.; Jiang, A.; Smith, R.Adam.; Maira, S-Michel.; Manning, H.Charles.; González-Angulo, A.M.; Mills, G.B.; Higham, C.; Chanthaphaychith, S.; Kuba, M.G.; Miller, W.R.; Shyr, Y.; Arteaga, C.L., 2012:
ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer

Eritja, N.; Mirantes, C.; Llobet, D.; Masip, G.; Matias-Guiu, X.; Dolcet, X., 2013:
ERα-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNFα and IL1α in lumen formation and maintenance

Brasseur, K.; Leblanc, V.; Fabi, F.; Parent, S.; Descôteaux, C.; Bérubé, G.; Asselin, E., 2013:
ERα-targeted therapy in ovarian cancer cells by a novel estradiol-platinum(II) hybrid

Byrne, C.; Khemtémourian, L.; Pelekanou, V.; Kampa, M.; Leclercq, G.; Sagan, S.; Castanas, E.; Burlina, F.; Jacquot, Y., 2012:
ERα17p, a peptide reproducing the hinge region of the estrogen receptor α associates to biological membranes: A biophysical approach

Kampa, M.; Pelekanou, V.; Gallo, D.; Notas, G.; Troullinaki, M.; Pediaditakis, I.; Charalampopoulos, I.; Jacquot, Y.; Leclercq, G.; Castanas, E., 2012:
ERα17p, an ERα P295 -T311 fragment, modifies the migration of breast cancer cells, through actin cytoskeleton rearrangements

Chen, Y.; Chen, L.; Li, J-Yu.; Mukaida, N.; Wang, Q.; Yang, C.; Yin, W-Jin.; Zeng, X-Hua.; Jin, W.; Shao, Z-ming., 2011:
ERβ and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells

Barone, M.; Scavo, M.Principia.; Papagni, S.; Piscitelli, D.; Guido, R.; Di Lena, M.; Comelli, M.Cristina.; Di Leo, A., 2011:
ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis

Xu, P.; Guo, L.; Tang, X.; Xu, H.; Fan, X., 2012:
ERβ may contribute to the maintaining of radial glia cells polarity through cadherins during corticogenesis

Nikolos, F.; Thomas, C.; Rajapaksa, G.; Bado, I.; Gustafsson, J-Åke., 2015:
ERβ regulates NSCLC phenotypes by controlling oncogenic RAS signaling

Pedram, A.; Razandi, M.; Korach, K.S.; Narayanan, R.; Dalton, J.T.; Levin, E.R., 2014:
ERβ selective agonist inhibits angiotensin-induced cardiovascular pathology in female mice

Wimberly, H.; Han, G.; Pinnaduwage, D.; Murphy, L.C.; Yang, X.Rose.; Andrulis, I.L.; Sherman, M.; Figueroa, J.; Rimm, D.L., 2015:
ERβ splice variant expression in four large cohorts of human breast cancer patient tumors

Monsivais, D.; Dyson, M.T.; Yin, P.; Coon, J.S.; Navarro, A.; Feng, G.; Malpani, S.S.; Ono, M.; Ercan, C.M.; Wei, J.J.; Pavone, M.E.; Su, E.; Bulun, S.E., 2015:
ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis

Greaves, E.; Collins, F.; Critchley, H.O.D.; Saunders, P.T.K., 2014:
ERβ-dependent effects on uterine endothelial cells are cell specific and mediated via Sp1

Zhao, G.; Nie, Y.; Lv, M.; He, L.; Wang, T.; Hou, Y., 2012:
ERβ-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine

Schleipen, B.; Hertrampf, T.; Fritzemeier, K.H.; Kluxen, F.M.; Lorenz, A.; Molzberger, A.; Velders, M.; Diel, P., 2011:
ERβ-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine

Horimoto, Y.; Hartman, J.; Millour, J.; Pollock, S.; Olmos, Y.; Ho, K-Kei.; Coombes, R.Charles.; Poutanen, M.; Mäkelä, S.I.; El-Bahrawy, M.; Speirs, V.; Lam, E.W-F., 2011:
ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer

Reese, J.M.; Suman, V.J.; Subramaniam, M.; Wu, X.; Negron, V.; Gingery, A.; Pitel, K.S.; Shah, S.S.; Cunliffe, H.E.; McCullough, A.E.; Pockaj, B.A.; Couch, F.J.; Olson, J.E.; Reynolds, C.; Lingle, W.L.; Spelsberg, T.C.; Goetz, M.P.; Ingle, J.N.; Hawse, J.R., 2015:
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

Anonymous, 1967:
ES Advisory Board Named

Anonymous, 1981:
ES Books

Anonymous, 1981:
ES Books

Anonymous, 1981:
ES Books

Anonymous, 1981:
ES Books

Anonymous, 1981:
ES Books

Anonymous, 1981:
ES Books

Goldman, B.A.; Hulme, J.A.; Johnson, C., 1987:
ES Books

Anonymous, 1987:
ES Books

Lioy, P.J.; Daisey, J.M., 1988:
ES Books -"Toxic Air Pollution: A Comprehensive Study of Non-Criteria Air"

Anonymous, 1988:
ES Books:

Park, C.C., 1988:
ES Books: Acid Rain: Rhetoric and Reality

White, J.C., 1988:
ES Books: Acid Rain: The Relationship Between Sources and Receptors

Seinfeld, J.H., 1986:
ES Books: Atmospheric Chemistry and Physics of Air Pollution

Forster, C.F.; Wase, D.A., 1988:
ES Books: Environmental Biotechnology

Tardiff, R.G.; Rodricks, J.V., 1988:
ES Books: Toxic Substances and Human Risk: Principles of Data Interpretation

Colman, A.; Alliston, D., 2007:
ES Cell International & regenerative medicine

Vanderlaan, M.; Watkins, B.E.; Stanker, L., 1988:
ES Critical Review: Environmental monitoring by immunoassay

Vogel, T.M.; Criddle, C.S.; McCarty, P.L., 1987:
ES Critical Reviews: Transformations of halogenated aliphatic compounds

Calabrese, E.J., 1987:
ES Feature: Animal extrapolation. A look inside the toxicologist's black box

Humenik, F.J.; Smolen, M.D.; Dressing, S.A., 1987:
ES Feature: Pollution from Nonpoint Sources

Anonymous, 1981:
ES Literature

Anonymous, 1981:
ES Literature

Anonymous, 1981:
ES Literature

Anonymous, 1981:
ES Literature

Anonymous, 1981:
ES Literature

Anonymous, 1981:
ES Literature

Anonymous, 1988:
ES Meetings

Anonymous, 1988:
ES Meetings

Anonymous, 1988:
ES Meetings

Anonymous, 1981:
ES Products

Anonymous, 1981:
ES Products

Anonymous, 1981:
ES Products

Anonymous, 1981:
ES Products

Anonymous, 1981:
ES Products

Anonymous, 1981:
ES Products

Anonymous, 1986:
ES Research: Ethical Guidelines to Publication of Chemical Research

Menzel, D.B., 1987:
ES Series: Cancer Risk Assessment. 2. Physiological pharmacokinetic modeling

Deisler, P.F., 1988:
ES Series: Cancer Risk Assessment. 5. The Risk Management-risk assessment interface

Ho, M.H.; Dillon, H.K., 1986:
ES Views: Biological monitoring

Krieger, Y.; Rubin, G.; Schulz, A.; Rosenberg, N.; Levi, A.; Singer, A.J.; Rosenberg, L.; Shoham, Y., 2018:
Bromelain-based enzymatic debridement and minimal invasive modality (mim) care of deeply burned hands

Postel, S., 1988:
ES Views: Controlling Toxic Chemicals

Cook, A.A., 1986:
ES Views: Environmental protection

Pfund, N.E., 1987:
ES Views: Environmental service laboratories

Hirschorn, J.S.; Oldenburg, K.U., 1987:
ES Views: Hazardous Waste: Prevention or Cleanup?

Josephson, J., 1986:
ES Views: Implementing Superfund

Hidy, G., 1985:
ES Views: Jekyll Island meeting report: George Hidy reports on the acquisition of reliable atmospheric data

Galloway, J., 1985:
ES Views: Jekyll Island meeting report: James Galloway compares acid deposition in remote areas with that found in industrialized areas

Paulk, J., 1988:
ES Views: National Network for Environmental Education

Simonin, H.A., 1988:
ES Views: Neutralization of acidic waters

Flavin, C., 1987:
ES Views: Nuclear Safety After Chernobyl

Bond, D., 1985:
ES Views: Ocean incineration of hazardous wastes: An update

Boyle, M., 1988:
ES Views: Radon testing of soils

Reid, N.J., 1987:
ES Views: Remote Sensing and Forest Damage

Santos, S.L., 1987:
ES Views: Risk assessment: A tool for risk management

Arcos, J.C., 1987:
ES Views: Structure-activity relationships

Purnell, J.H., 1988:
ES Views: The Global Environment

Anonymous, 1986:
ES Views: Turning detection into protection

Yamashita, J.K., 2010:
ES and iPS cell research for cardiovascular regeneration

Barry, E.R.; Krueger, W.; Jakuba, C.M.; Veilleux, E.; Ambrosi, D.J.; Nelson, C.E.; Rasmussen, T.P., 2009:
ES cell cycle progression and differentiation require the action of the histone methyltransferase Dot1L

Kohama, C.; Kato, H.; Numata, K.; Hirose, M.; Takemasa, T.; Ogura, A.; Kiyosawa, H., 2012:
ES cell differentiation system recapitulates the establishment of imprinted gene expression in a cell-type-specific manner

Xu, Y-Ning.; Guan, N.; Wang, Z-Dong.; Shan, Z-Yan.; Shen, J-Ling.; Zhang, Q-Hua.; Jin, L-Hong.; Lei, L., 2009:
ES cell extract-induced expression of pluripotent factors in somatic cells

Kern, H.; Zevnik, B., 2009:
ES cell line establishment

Karki, S.; Pruszak, J.; Isacson, O.; Sonntag, K.C., 2008:
ES cell-derived neuroepithelial cell cultures

Coulombel, L., 2012:
ES cells and postnatal chimeric Rhesus monkeys

Glass, C.; Singla, D.K., 2012:
ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium

Liu, Z.; Wan, P.; Duan, H.; Zhou, J.; Tan, B.; Liu, Y.; Zhou, Q.; Zhou, C.; Huang, Z.; Tian, B.; Li, C.; Wang, Z., 2013:
ES micro-environment enhances stemness and inhibits apoptosis in human limbal stem cells via the maintenance of telomerase activity

Anonymous, 2007:
ES research in Australia

Anonymous, 1995:
ES&T Advisory Board: 1996 Advisory Board

Anonymous, 1997:
ES&T Advisory Board: 1997 Advisory Board

Anonymous, 1999:
ES&T Europe: ES&T

Anonymous, 1995:
ES&T Information

Anonymous, 1994:
ES&T Information Express

Anonymous, 1994:
ES&T Information Express

Anonymous, 1995:
ES&T Information Express

Anonymous, 1995:
ES&T Information Express

Anonymous, 1987:
ES&T Letters Airborne Chemicals

Anonymous, 1985:
ES&T Letters Correction

Anonymous, 1986:
ES&T Letters: Acid Deposition

Anonymous, 1986:
ES&T Letters: Risk Assessments

Hertwich, E.G., 2014:
ES&T and the IPCC

Glaze, W.H., 1999:
ES&T in the new millennium

Schnoor, J.L., 2011:
ES&T's Best Papers of 2010

Schnoor, J.L., 2014:
ES&T's best papers of 2013: under pressure

Anonymous, 1994:
ES&T: A New Forum for Research in Policy Analysis

Anonymous, 1984:
ES&Ts 1984 Advisory Board

Pozzobon, M.; Ghionzoli, M.; De Coppi, P., 2010:
ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective

Pineda, M.A.; Rodgers, D.T.; Al-Riyami, L.; Harnett, W.; Harnett, M.M., 2014:
ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints

Pineda, M.A.; Lumb, F.; Harnett, M.M.; Harnett, W., 2015:
ES-62, a therapeutic anti-inflammatory agent evolved by the filarial nematode Acanthocheilonema viteae

Bonde, S.; Chan, K-Ming.; Zavazava, N., 2008:
ES-cell derived hematopoietic cells induce transplantation tolerance

Philippens, M.; Wismans, J.; Forbes, P.A.; Yoganandan, N.; Pintar, F.A.; Soltis, S.J., 2010:
ES2 neck injury assessment reference values for lateral loading in side facing seats

González-Aragón, D.; Alcaín, F.J.; Ariza, J.; Jódar, L.; Barbarroja, N.; López-Pedrera, C.; Villalba, Jé.M., 2010:
ES936 stimulates DNA synthesis in HeLa cells independently on NAD(P)H:quinone oxidoreductase 1 inhibition, through a mechanism involving p38 MAPK

Wittmann, M.; Matot, I.; Hoeft, A., 2014:
ESA Clinical Trials Network 2012

Meier, J.; Kozek-Langenecker, S.; Filipescu, D.; Pitarch, J.V.L.; Mallett, S.; Martus, P.; Matot, I., 2014:
ESA Clinical Trials Network 2012: ETPOS--European Transfusion Practice and Outcome Study

Hemmes, S.N.T.; de Abreu, M.Gama.; Pelosi, P.; Schultz, M.J., 2014:
ESA Clinical Trials Network 2012: LAS VEGAS--Local Assessment of Ventilatory Management during General Anaesthesia for Surgery and its effects on Postoperative Pulmonary Complications: a prospective, observational, international, multicentre cohort study

Lirk, P.; Stadlbauer, K-Heinz.; Hollmann, M.W., 2014:
ESA Clinical Trials Network 2012: PLATA--Prevention of Phantom Limb Pain After Transtibial Amputation: randomised, double-blind, controlled, multicentre trial comparing optimised intravenous pain control versus optimised intravenous pain control plus regional anaesthesia

Koenig, R., 1995:
ESA Members Balk at Space Station Cost

Waldrop, M.M., 1983:
ESA Wants to Help Build a Space Station

Szczech, L., 2013:
ESA dose vs. Hb levels: what needs to be monitored?

Kruger, A.; Trowbridge, L.; York, J.; Butcher, B.; Bradley, J., 2013:
ESA frequency and hemoglobin levels in patients on peritoneal dialysis: 2002 vs. 2008

Sancesario, G.M.; Nuccetelli, M.; Cerri, A.; Zegeer, J.; Severini, C.; Ciotti, M.T.; Pieri, M.; Martorana, A.; Caltagirone, C.; Nistico, R.; Bernardini, S., 2018:
Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer's Disease Patients

Sargent, J.A., 2008:
ESA payment changes: chasing a moving target

Biggar, P.; Ketteler, M., 2013:
ESA therapy - the quest continues: anemia treatment following recent national and international recommendations 2011 and 2012

McAllister, C.J., 2007:
ESA therapy for anemia management: a call for civil discourse

Taylor, F.W., 1994:
ESA's Planetary Program

Chatterjee, R., 2007 :
ESA: politics endangers science

Kieran, J.A.; O'Doherty, R.G.; Hudson, B.J., 2011:
ESAC point prevalence methodology to assess antimicrobial consumption and quality of prescribing in an Australian setting

Macdonald, C., 1995:
ESACT meeting overview: Back to the future

Mikkola, H., 2009:
ESAM: adding to the hematopoietic toolbox

Downing, G.Michael.; Downing, T., 2013:
ESAS, CABG, and the personal experience of two palliative clinicians

Beuker, K.T.; Schjølberg, S.; Lie, K.Kveim.; Swinkels, S.; Rommelse, N.N.J.; Buitelaar, J.K., 2015:
ESAT and M-CHAT as screening instruments for autism spectrum disorders at 18 months in the general population: issues of overlap and association with clinical referrals

Hoang, T.; Aagaard, C.; Dietrich, J.; Cassidy, J.P.; Dolganov, G.; Schoolnik, G.K.; Lundberg, C.Vingsbo.; Agger, E.Marie.; Andersen, P., 2014:
ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination

Fox, A.; Jeffries, D.J.; Hill, P.C.; Hammond, A.S.; Lugos, M.D.; Jackson-Sillah, D.; Donkor, S.A.; Owiafe, P.K.; McAdam, K.P.W.J.; Brookes, R.H., 2007:
ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease

Marongiu, L.; Donini, M.; Toffali, L.; Zenaro, E.; Dusi, S., 2014:
ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation

Wang, X.; Barnes, P.F.; Dobos-Elder, K.M.; Townsend, J.C.; Chung, Y-tae.; Shams, H.; Weis, S.E.; Samten, B., 2009 :
ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells

Bottai, D.; Majlessi, L.; Simeone, R.; Frigui, W.; Laurent, C.; Lenormand, P.; Chen, J.; Rosenkrands, I.; Huerre, M.; Leclerc, C.; Cole, S.T.; Brosch, R., 2011:
ESAT-6 secretion-independent impact of ESX-1 genes espF and espG1 on virulence of Mycobacterium tuberculosis

Qiao, D.; Yang, B.Y.; Li, L.; Ma, J.J.; Zhang, X.L.; Lao, S.H.; Wu, C.Y., 2011:
ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection

Weldingh, K.; Andersen, P., 2008:
ESAT-6/CFP10 skin test predicts disease in M. tuberculosis-infected guinea pigs

Hasan, Z.; Jamil, B.; Ashraf, M.; Islam, M.; Yusuf, M.S.; Khan, J.A.; Hussain, R., 2009:
ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis

Beserab, A., 2013:
ESAs and irons in the pipeline: how do they differ?

Brower, V., 2008:
ESAs further restricted, but debate continues

Singh, A.K., 2010:
ESAs in dialysis patients: are you a hedgehog or a fox?

Mehrotra, A., 2012:
ESAs in transplant anemia: one size does not "fit all"

Ludwig, H.; Anderson, K.; Dammacco, F.; Hedenus, M.; Osterborg, A.; Durie, B., 2008:
ESAs not the culprit: more studies required

Heinlein, B.; Kutzner, I.; Graichen, F.; Bender, A.; Rohlmann, A.; Halder, A.M.; Beier, A.; Bergmann, G., 2009:
ESB Clinical Biomechanics Award 2008: Complete data of total knee replacement loading for level walking and stair climbing measured in vivo with a follow-up of 6-10 months

Stoimenov, L.; Bogdanovic, M.; Bogdanovic-Dinic, S., 2014:
ESB-based Sensor Web integration for the prediction of electric power supply system vulnerability

Tan, Y.; Li, P., 2018:
Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor

Tiemann, K., 2009:
ESBES meeting report: Get-together -international bioengineers meet in Faro

Wang, X.; He, L.; Wei, B.; Yan, G.; Wang, J.; Tang, R., 2018:
Bromelain-immobilized and lactobionic acid-modified chitosan nanoparticles for enhanced drug penetration in tumor tissues

Panknin, H-Thorsten.; Trautmann, M., 2012:
ESBL (extended spectrum β-lactamase) pathogens in the newborn unit: harmless colonizing bacteria or mortal threat?

Ishii, Y., 2007:
ESBL and its producing organism

Lagacé-Wiens, P.Rs.; Nichol, K.A.; Nicolle, L.E.; Decorby, M.R.; McCracken, M.; Alfa, M.J.; Mulvey, M.R.; Zhanel, G.G., 2008:
ESBL genotypes in fluoroquinolone-resistant and fluoroquinolone-susceptible ESBL-producing Escherichia coli urinary isolates in Manitoba

Ishii, Y., 2012:
ESBL producing organisms

Bongaerts, G.; Piebes, A., 2010:
ESBL reduction via veterinary use of probiotics?

Haneveld, J.Klein., 2010:
ESBL's: increase is alarming, but no reason to panic

Oberoi, L.; Singh, N.; Sharma, P.; Aggarwal, A., 2013:
ESBL, MBL and Ampc β Lactamases Producing Superbugs - Havoc in the Intensive Care Units of Punjab India

Anssour, L.; Messai, Y.; Derkaoui, M.; Alouache, S.; Estepa, V.; Somalo, S.; Torres, C.; Bakour, R., 2014:
ESBL, plasmidic AmpC, and associated quinolone resistance determinants in coliforms isolated from hospital effluent: first report of qnrB2, qnrB9, qnrB19, and blaCMY-4 in Algeria

Owlia, P.; Azimi, L.; Gholami, A.; Asghari, B.; Lari, A.Rastegar., 2013:
ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients

Hallgren, H.; Gustafsson, I.; Ripa, T., 2008:
ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections

Giske, C.G.; Kalin, M., 2013:
ESBL-CARBA can become a problem in Swedish health care

Schaufler, K.; Wieler, L.H.; Semmler, T.; Ewers, C.; Guenther, S., 2013:
ESBL-plasmids carrying toxin-antitoxin systems can be "cured" of wild-type Escherichia coli using a heat technique

De Boeck, H.; Miwanda, B.; Lunguya-Metila, O.; Muyembe-Tamfum, J-Jacques.; Stobberingh, E.; Glupczynski, Y.; Jacobs, J., 2012:
ESBL-positive Enterobacteria isolates in drinking water

Sekowska, A.; Wróblewska, J.; Gospodarek, E., 2008:
ESBL-positive and ESBL-negative Klebsiella pneumoniae and Klebsiella oxytoca strains--occurrence in clinical specimens and susceptibility to selected antibiotics

Franiek, N.; Orth, D.; Grif, K.; Ewers, C.; Wieler, L.H.; Thalhammer, J.G.; Würzner, R., 2014:
ESBL-producing E. coli and EHEC in dogs and cats in the Tyrol as possible source of human infection

Alsultan, A.A.; Aboulmagd, E.; Amin, T.T., 2014:
ESBL-producing E. coli and K. pneumoniae in Al-Ahsa, Saudi Arabia: antibiotic susceptibility and prevalence of blaSHV and blaTEM

Reinthaler, F.Ferdinand.; Feierl, G.; Galler, H.; Haas, D.; Leitner, E.; Mascher, F.; Melkes, A.; Posch, J.; Winter, I.; Zarfel, G.; Marth, E., 2010:
ESBL-producing E. coli in Austrian sewage sludge

Storberg, V., 2014:
ESBL-producing Enterobacteriaceae in Africa - a non-systematic literature review of research published 2008-2012

Haque, A.; Yoshizumi, A.; Saga, T.; Ishii, Y.; Tateda, K., 2015:
ESBL-producing Enterobacteriaceae in environmental water in Dhaka, Bangladesh

Bissett, L., 2007:
ESBL-producing Enterobacteriaceae: controlling the spread of infection

Reist, M.; Geser, N.; Hächler, H.; Schärrer, S.; Stephan, R., 2014:
ESBL-producing Enterobacteriaceae: occurrence, risk factors for fecal carriage and strain traits in the Swiss slaughter cattle population younger than 2 years sampled at abattoir level

Somily, A.Mohammed.; Habib, H.A.; Absar, M.M.; Arshad, M.Z.; Manneh, K.; Al Subaie, S.S.; Al Hedaithy, M.A.; Sayyed, S.B.; Shakoor, Z.; Murray, T.S., 2015:
ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia

Franiczek, R.; Sobieszczańska, B.; Turniak, Mł.; Kasprzykowska, U.; Krzyzanowska, B.; Jermakow, K.; Mokracka-Latajka, G., 2013:
ESBL-producing Escherichia coli isolated from children with acute diarrhea - antimicrobial susceptibility, adherence patterns and phylogenetic background

González-López, J.José.; Piedra-Carrasco, N.; Salvador, F.; Rodríguez, V.; Sánchez-Montalvá, Aán.; Planes, A.M.; Molina, I.; Larrosa, M.Nieves., 2015:
ESBL-producing Salmonella enterica serovar Typhi in traveler returning from Guatemala to Spain

Silley, P., 2007:
ESBL-producing bacteria isolated from companion animals

Lago, A.; Fuentefria, S.Roberto.; Fuentefria, D.Bopp., 2011:
ESBL-producing enterobacteria in Passo Fundo, state of Rio Grande do Sul, Brazil

Taneja, N.; Sharma, M., 2008:
ESBLs detection in clinical microbiology: why & how?

Dhillon, R.H-P.; Clark, J., 2011:
ESBLs: A Clear and Present Danger?

Feng, X.; Hang, S.; Zhou, Y.; Liu, Q.; Yang, H., 2018:
Bromelain Kinetics and Mechanism on Myofibril from Golden Pomfret (Trachinotus blochii)

Costantini, S.; Colonna, G.; Facchiano, A.M., 2009:
ESBRI: a web server for evaluating salt bridges in proteins

Loriot, Sébastien.; Cazals, Fédéric.; Bernauer, J., 2010:
ESBTL: efficient PDB parser and data structure for the structural and geometric analysis of biological macromolecules

Dewey, H., 2008:
ESC 2006: exciting trial results released

Taylor, J., 2013:
ESC 2012 clinical trial and registry updates I

D.Palma, R., 2013:
ESC 2012--interventional highlights

van der Wall, E.E., 2008:
ESC Congress 2008 in Munich: Hot news from Hot lines!

Ataide, Jína.Artem.; Gérios, E.Favero.; Mazzola, P.Gava.; Souto, E.B., 2018:
Bromelain-loaded nanoparticles: A comprehensive review of the state of the art

Daemen, J.; Simoons, M.L.; Wijns, W.; Bagust, A.; Bos, G.; Bowen, J.M.; Braunwald, E.; Camenzind, E.; Chevalier, B.; Dimario, C.; Fajadet, J.; Gitt, A.; Guagliumi, G.; Hillege, H.L.; James, S.; Jüni, P.; Kastrati, A.; Kloth, S.; Kristensen, S.D.; Krucoff, M.; Legrand, V.; Pfisterer, M.; Rothman, M.; Serruys, P.W.; Silber, S.; Steg, P.G.; Tariah, I.; Wallentin, L.; Windecker, S.W.; Aimonetti, A.; Allocco, D.; Baczynska, A.; Bagust, A.; Berenger, M.; Bos, G.; Boam, A.; Bowen, J.M.; Braunwald, E.;, 2008:
ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007

Steg, P.Gabriel.; James, S.K.; Atar, D.; Badano, L.P.; Blömstrom-Lundqvist, C.; Borger, M.A.; D.M.rio, C.; Dickstein, K.; Ducrocq, G.; Fernandez-Aviles, F.; Gershlick, A.H.; Giannuzzi, P.; Halvorsen, S.; Huber, K.; Juni, P.; Kastrati, A.; Knuuti, J.; Lenzen, M.J.; Mahaffey, K.W.; Valgimigli, M.; van 't Hof, A.; Widimsky, P.; Zahger, D.; Bax, J.J.; Baumgartner, H.; Ceconi, C.; Dean, V.; Deaton, C.; Fagard, R.; Funck-Brentano, C.; Hasdai, D.; Hoes, A.; Kirchhof, P.; Knuuti, J.; Kolh, P.; McD, 2013:
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Baumgartner, H.; Bonhoeffer, P.; D.G.oot, N.M.S.; de Haan, F.; Deanfield, J.Erik.; Galie, N.; Gatzoulis, M.A.; Gohlke-Baerwolf, C.; Kaemmerer, H.; Kilner, P.; Meijboom, F.; Mulder, B.J.M.; Oechslin, E.; Oliver, J.M.; Serraf, A.; Szatmari, A.; Thaulow, E.; Vouhe, P.R.; Walma, E.; Vahanian, A.; Auricchio, A.; Bax, J.; Ceconi, C.; Dean, V.; Filippatos, G.; Funck-Brentano, C.; Hobbs, R.; Kearney, P.; McDonagh, T.; Popescu, B.A.; Reiner, Z.; Sechtem, U.; Sirnes, P.Anton.; Tendera, M.; Vardas, P.; Wid, 2011:
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)

Passali, D.; Passali, G.C.; Bellussi, L.M.; Sarafoleanu, C.; Loglisci, M.; Manea, C.; Iosif, C.; Passali, F.M., 2018:
Bromelain's penetration into the blood and sinonasal mucosa in patients with chronic rhinosinusitis

Anonymous, 2018:

Anonymous, 2018:
Bromhydrate of Quinine

Cummins, P.; Serruys, P.W., 2013:
ESC Journals working together

Leite-Moreira, A.F.; Lourenço, Aé.P.; Balligand, J-Luc.; Bauersachs, J.; Clerk, A.; D.W.ndt, L.J.; Heymans, S.; Hilfiker-Kleiner, D.; Hirsch, E.; Iaccarino, G.; Kaminski, K.A.; Knöll, R.; Mayr, M.; Tarone, G.; Thum, T.; Tocchetti, C.G., 2015:
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models

Rosenhek, R.; Iung, B.; Tornos, P.; Antunes, M.J.; Prendergast, B.D.; Otto, C.M.; Kappetein, A.Pieter.; Stepinska, J.; Kaden, J.J.; Naber, C.K.; Acartürk, E.; Gohlke-Bärwolf, C., 2012:
ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease

Lancellotti, P.; Rosenhek, R.; Pibarot, P.; Iung, B.; Otto, C.M.; Tornos, P.; Donal, E.; Prendergast, B.; Magne, J.; L.C.nna, G.; Piérard, L.A.; Maurer, G., 2014:
ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences

Gillebert, T.C.; Brooks, N.; Fontes-Carvalho, R.; Fras, Z.; Gueret, P.; Lopez-Sendon, J.; Salvador, M.Jesus.; van den Brink, R.B.A.; Smiseth, O.A.; Griebenow, R., 2014:
ESC core curriculum for the general cardiologist (2013)

Goto, D.; Tsutsui, H., 2007:
ESC guidelines

Pfister, R.; Schneider, C.A., 2009:
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides

Liu, B.; Wu, P.; Huang, Z.; Ma, L.; Liu, J., 2018:
Bromide as a Robust Backfiller on Gold for Precise Control of DNA Conformation and High Stability of Spherical Nucleic Acids

Yu, J.; Hong, Z.; Yang, X.; Jiang, Y.; Jiang, Z.; Su, W., 2018:
Bromide-assisted chemoselective Heck reaction of 3-bromoindazoles under high-speed ball-milling conditions: synthesis of axitinib

Cohen, I.; Shapira, B.; Avraham, E.; Soffer, A.; Aurbach, D., 2018:
Bromide Ions Specific Removal and Recovery by Electrochemical Desalination

Rydén, L.; Grant, P.J.; Anker, S.D.; Berne, C.; Cosentino, F.; Danchin, N.; Deaton, C.; Escaned, J.; Hammes, H-Peter.; Huikuri, H.; Marre, M.; Marx, N.; Mellbin, L.; Ostergren, J.; Patrono, C.; Seferovic, P.; Sousa Uva, M.; Taskinen, M-Riita.; Tendera, Mł.; Tuomilehto, J.; Valensi, P.; Zamorano, J.Luis.; Zamorano, J.Luis.; Achenbach, S.; Baumgartner, H.; Bax, J.J.; Bueno, Héctor.; Dean, V.; Deaton, C.; Erol, Çetin.; Fagard, R.; Ferrari, R.; Hasdai, D.; Hoes, A.W.; Kirchhof, P.; Knuuti, J.; K, 2014:
ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD

Rydén, L.; Grant, P.J.; Anker, S.D.; Berne, C.; Cosentino, F.; Danchin, N.; Deaton, C.; Escaned, J.; Hammes, H-Peter.; Huikuri, H.; Marre, M.; Marx, N.; Mellbin, L.; Ostergren, J.; Patrono, C.; Seferovic, P.; Uva, M.Sousa.; Taskinen, M-Riita.; Tendera, M.; Tuomilehto, J.; Valensi, P.; Zamorano, J.Luis.; Zamorano, J.Luis.; Achenbach, S.; Baumgartner, H.; Bax, J.J.; Bueno, Héctor.; Dean, V.; Deaton, C.; Erol, C.; Fagard, R.; Ferrari, R.; Hasdai, D.; Hoes, A.W.; Kirchhof, P.; Knuuti, J.; Kolh, P., 2015:
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary

Van de Werf, F.; Bax, J.; Betriu, A.; Blomstrom-Lundqvist, C.; Crea, F.; Falk, V.; Filippatos, G.; Fox, K.; Huber, K.; Kastrati, A.; Rosengren, A.; Steg, P.Gabriel.; Tubaro, M.; Verheugt, F.; Weidinger, F.; Weis, M., 2010:
ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation

Mangner, N.; Schuler, G., 2014:
ESC guidelines on the management of valvular heart disease. What has changed and what is new?

Tofield, A., 2014:
ESC opens Brussels Bureau: the European Heart Agency

Taylor, J., 2011:
ESC recommendations for individual certification and institutional cardiovascular magnetic resonance accreditation, in Europe

Kirby, T., 2010:
ESC tackles child congenital heart disease in poor countries

Lecour, S.; Bøtker, H.E.; Condorelli, G.; Davidson, S.M.; Garcia-Dorado, D.; Engel, F.B.; Ferdinandy, P.; Heusch, G.; Madonna, R.; Ovize, M.; Ruiz-Meana, M.; Schulz, R.; Sluijter, J.P.G.; Van Laake, L.W.; Yellon, D.M.; Hausenloy, D.J., 2015:
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies

Baron, J-C.; Macrae, I.M.; Adams, H.P.; Dirnagl, U., 2014:
ESC-BRAIN: experimental and clinical stroke research--do they connect?. Meeting report of the ESC-BRAIN joint symposium held in London and Shanghai in May 2013

Arbelo, E.; Brugada, J.; Hindricks, G.; Maggioni, A.; Tavazzi, L.; Vardas, P.; Anselme, Fédéric.; Inama, G.; Jais, P.; Kalarus, Z.; Kautzner, J.; Lewalter, T.; Mairesse, G.; Perez-Villacastin, J.; Riahi, S.; Taborsky, M.; Theodorakis, G.; Trines, S.; Brugada, J.; Arbelo, E.; Hindriks, G.; Maggioni, A.; Morgan, J.; Tavazzi, L.; Vardas, P.; Alonso, A.; Ferrari, R.; Komajda, M.; Tavazzi, L.; Wood, D.; Brugada, J.; Mairesse, G.; Taborsky, M.; Kautzner, J.; Lewalter, T.; Riahi, S.; Jais, P.; Anselm, 2013:
ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association

Taylor, J., 2013:
ESC/EACTS Guidelines on the management of valvular heart disease

Nef, H.; Renker, M.; Hamm, C.W., 2015:
ESC/EACTS guidelines on myocardial revascularization : Amendments 2014

Mohr, F.W.; Davierwala, P.M., 2015:
ESC/EACTS guidelines on myocardial revascularization post-SYNTAX

Melandri, G.; Vagnarelli, F.; Cinti, L.; Branzi, A., 2011:
ESC/EACTS guidelines on myocardial revascularization: shadows, lights and haze: the clinical cardiologist's point of view

Vitali, E., 2011:
ESC/EACTS guidelines on myocardial revascularization: the cardiac surgeon's point of view

Indolfi, C., 2011:
ESC/EACTS guidelines on myocardial revascularization: the interventional cardiologist's point of view

Reiner, Željko.; Catapano, A.L.; D.B.cker, G.; Graham, I.; Taskinen, M-Riitta.; Wiklund, O.; Agewall, S.; Alegría, E.; Chapman, M.John.; Durrington, P.; Erdine, S.; Halcox, J.; Hobbs, R.Hobbs.; Kjekshus, J.Kjekshus.; Perrone Filardi, P.; Riccardi, G.; Storey, R.F.; David, W., 2012:
ESC/EAS Guidelines for the management of dyslipidaemias

Anonymous, 1873:
Bromide of Calcium in the Treatment of Syphilitic Neuralgia

Anonymous, 2018:
Bromide of Strontium in the Treatment of Epilepsy

Motz, W.; Dörr, R., 2009:
ESC/EASD joint guidelines on diabetes and cardiovascular diseases

Hirokawa, K.; Danzaki, Y.; Oku, M., 1981:
ESCA Investigation of the surface of mixed precipitates

Giesecke, J., 2010:
ESCAIDE 2010 - an opportunity for sharing knowledge, building capacity and strengthening networks

Anonymous, 2018:
Bromide Rashes

de Ruijter, Aëlle.M., 2014:
ESCAP online: integrating alignment and internet technology in our vision on international CAP relations

Christiaans, I.; Dijksman, L.M.; Birnie, E., 2007:
ESCAPE-HCM study: Evaluation of SCreening of Asymptomatic PatiEnts with Hypertrophic CardioMyopathy

Lebeau, J-Pierre.; Pouchain, D.; Huas, D.; Wilmart, F.; Dibao-Dina, C.; Boutitie, F., 2011:
ESCAPE-ancillary blood pressure measurement study: end-digit preference in blood pressure measurement within a cluster-randomized trial

Siragy, H.M., 2010:
ESCAPE: From hypertension to renal failure

Xu, H.; Baroukh, C.; Dannenfelser, R.; Chen, E.Y.; Tan, C.M.; Kou, Y.; Kim, Y.E.; Lemischka, I.R.; Ma'ayan, A., 2013:
ESCAPE: database for integrating high-content published data collected from human and mouse embryonic stem cells

Jain, R.; Gupta, S.; Pasricha, N.; Faujdar, M.; Sharma, M.; Mishra, P., 2010:
ESCC with metastasis in the young age of caustic ingestion of shortest duration

Gutierrez, H.H.; Mogayzel, P.J., 2015:
ESCF care guidelines beyond Europe

Li, H.; La Guardia, M.J.; Liu, H.; Hale, R.C.; Mainor, T.Matteson.; Harvey, E.; Sheng, G.; Fu, J.; Peng, P'an., 2018:
Brominated and organophosphate flame retardants along a sediment transect encompassing the Guiyu, China e-waste recycling zone

Umansky, V.; Guinn, B-ann., 2010:
ESCII-PIVAC meeting "Recent advances in cancer immunotherapy with an emphasis on cancer vaccines" held in Athens, 9-11 October 2008

Anonymous, 2010:
ESCMID Consensus concerning MRSA

Cornely, O.A.; Arikan-Akdagli, S.; Dannaoui, E.; Groll, A.H.; Lagrou, K.; Chakrabarti, A.; Lanternier, F.; Pagano, L.; Skiada, A.; Akova, M.; Arendrup, M.C.; Boekhout, T.; Chowdhary, A.; Cuenca-Estrella, M.; Freiberger, T.; Guinea, J.; Guarro, J.; de Hoog, S.; Hope, W.; Johnson, E.; Kathuria, S.; Lackner, M.; Lass-Flörl, C.; Lortholary, O.; Meis, J.F.; Meletiadis, J.; Muñoz, P.; Richardson, M.; Roilides, E.; Tortorano, A.M.; Ullmann, A.J.; van Diepeningen, A.; Verweij, P.; Petrikkos, G., 2014:
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

Arendrup, M.C.; Boekhout, T.; Akova, M.; Meis, J.F.; Cornely, O.A.; Lortholary, O.; Arikan-Akdagli, S.; Cuenca-Estrella, M.; Dannaoui, E.; van Diepeningen, A.D.; Groll, A.H.; Guarro, J.; Guinea, Jús.; Hope, W.; Lackner, M.; Lass-Flörl, C.; Lagrou, K.; Lanternier, F.; Meletiadis, J.; Munoz, P.; Marañón, G.; Pagano, L.; Richardson, M.D.; Roilides, E.; Tortorano, A.Maria.; Ullmann, A.J., 2014:
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

Chowdhary, A.; Meis, J.F.; Guarro, J.; de Hoog, G.S.; Kathuria, S.; Arendrup, M.C.; Arikan-Akdagli, S.; Akova, M.; Boekhout, T.; Caira, M.; Guinea, J.; Chakrabarti, A.; Dannaoui, E.; van Diepeningen, A.; Freiberger, T.; Groll, A.H.; Hope, W.W.; Johnson, E.; Lackner, M.; Lagrou, K.; Lanternier, F.; Lass-Flörl, C.; Lortholary, O.; Meletiadis, J.; Muñoz, P.; Pagano, L.; Petrikkos, G.; Richardson, M.D.; Roilides, E.; Skiada, A.; Tortorano, A.M.; Ullmann, A.J.; Verweij, P.E.; Cornely, O.A.; Cuenca-, 2014:
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

Tortorano, A.M.; Richardson, M.; Roilides, E.; van Diepeningen, A.; Caira, M.; Munoz, P.; Johnson, E.; Meletiadis, J.; Pana, Z-D.; Lackner, M.; Verweij, P.; Freiberger, T.; Cornely, O.A.; Arikan-Akdagli, S.; Dannaoui, E.; Groll, A.H.; Lagrou, K.; Chakrabarti, A.; Lanternier, F.; Pagano, L.; Skiada, A.; Akova, M.; Arendrup, M.C.; Boekhout, T.; Chowdhary, A.; Cuenca-Estrella, M.; Guinea, J.; Guarro, J.; de Hoog, S.; Hope, W.; Kathuria, S.; Lortholary, O.; Meis, J.F.; Ullmann, A.J.; Petrikkos, G.;, 2014:
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

Tacconelli, E.; Cataldo, M.A.; Dancer, S.J.; D.A.gelis, G.; Falcone, M.; Frank, U.; Kahlmeter, G.; Pan, A.; Petrosillo, N.; Rodríguez-Baño, J.; Singh, N.; Venditti, M.; Yokoe, D.S.; Cookson, B., 2014:
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

Pilloux, L.; Greub, G., 2015:
ESCMID postgraduate technical workshop on intracellular bacteria: from biology to clinic

Ullmann, A.J.; Akova, M.; Herbrecht, R.; Viscoli, C.; Arendrup, M.C.; Arikan-Akdagli, S.; Bassetti, M.; Bille, J.; Calandra, T.; Castagnola, E.; Cornely, O.A.; Donnelly, J.P.; Garbino, J.; Groll, A.H.; Hope, W.W.; Jensen, H.E.; Kullberg, B.J.; Lass-Flörl, C.; Lortholary, O.; Meersseman, W.; Petrikkos, G.; Richardson, M.D.; Roilides, E.; Verweij, P.E.; Cuenca-Estrella, M., 2013:
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Ullmann, A.J.; Cornely, O.A.; Donnelly, J.P.; Akova, M.; Arendrup, M.C.; Arikan-Akdagli, S.; Bassetti, M.; Bille, J.; Calandra, T.; Castagnola, E.; Garbino, J.; Groll, A.H.; Herbrecht, R.; Hope, W.W.; Jensen, H.E.; Kullberg, B.J.; Lass-Flörl, C.; Lortholary, O.; Meersseman, W.; Petrikkos, G.; Richardson, M.D.; Roilides, E.; Verweij, P.E.; Viscoli, C.; Cuenca-Estrella, M., 2013:
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases

Cuenca-Estrella, M.; Verweij, P.E.; Arendrup, M.C.; Arikan-Akdagli, S.; Bille, J.; Donnelly, J.P.; Jensen, H.E.; Lass-Flörl, C.; Richardson, M.D.; Akova, M.; Bassetti, M.; Calandra, T.; Castagnola, E.; Cornely, O.A.; Garbino, J.; Groll, A.H.; Herbrecht, R.; Hope, W.W.; Kullberg, B.J.; Lortholary, O.; Meersseman, W.; Petrikkos, G.; Roilides, E.; Viscoli, C.; Ullmann, A.J., 2013:
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

Cornely, O.A.; Bassetti, M.; Calandra, T.; Garbino, J.; Kullberg, B.J.; Lortholary, O.; Meersseman, W.; Akova, M.; Arendrup, M.C.; Arikan-Akdagli, S.; Bille, J.; Castagnola, E.; Cuenca-Estrella, M.; Donnelly, J.P.; Groll, A.H.; Herbrecht, R.; Hope, W.W.; Jensen, H.E.; Lass-Flörl, C.; Petrikkos, G.; Richardson, M.D.; Roilides, E.; Verweij, P.E.; Viscoli, C.; Ullmann, A.J., 2013:
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

Lortholary, O.; Petrikkos, G.; Akova, M.; Arendrup, M.C.; Arikan-Akdagli, S.; Bassetti, M.; Bille, J.; Calandra, T.; Castagnola, E.; Cornely, O.A.; Cuenca-Estrella, M.; Donnelly, J.P.; Garbino, J.; Groll, A.H.; Herbrecht, R.; Hope, W.W.; Jensen, H.E.; Kullberg, B.J.; Lass-Flörl, C.; Meersseman, W.; Richardson, M.D.; Roilides, E.; Verweij, P.E.; Viscoli, C.; Ullmann, A.J., 2013:
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS

Hope, W.W.; Castagnola, E.; Groll, A.H.; Roilides, E.; Akova, M.; Arendrup, M.C.; Arikan-Akdagli, S.; Bassetti, M.; Bille, J.; Cornely, O.A.; Cuenca-Estrella, M.; Donnelly, J.P.; Garbino, J.; Herbrecht, R.; Jensen, H.E.; Kullberg, B.J.; Lass-Flörl, C.; Lortholary, O.; Meersseman, W.; Petrikkos, G.; Richardson, M.D.; Verweij, P.E.; Viscoli, C.; Ullmann, A.J., 2013:
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp

Soares, A.Paula.; Medeiros, Jé.Carlos.; Simões, A.; Machado, Jão.; Costa, A.; Iriarte, Álvaro.; de Almeida, Jé.João.; Pinheiro, A.P.; Comesaña, M., 2014:
ESCOLEX: a grade-level lexical database from European Portuguese elementary to middle school textbooks

Krenn, L., 2013:
ESCOP on-line: new monographs available!

Bilia, A.Rita.; Frater-Schröder, M.; Krenn, L.; Steinhoff, B., 2011:
ESCOP's role in defining a scientific foundation for herbal medicinal products

Påhlman, L.; Matzel, K., 2007:
ESCP Report. Division of Coloproctology (UEMS) (2007)

Devereaux, M.; Kalichman, M., 2013:
ESCRO committees--not dead yet

Roxrud, I.; Stenmark, H.; Malerød, L., 2010:

Jimenez, A.Joaquina.; Maiuri, P.; Lafaurie-Janvore, J.; Divoux, Séverine.; Piel, M.; Perez, F., 2014:
ESCRT machinery is required for plasma membrane repair

Ehrlich, L.S.; Medina, G.N.; Carter, C.A., 2011:
ESCRT machinery potentiates HIV-1 utilization of the PI(4,5)P(2)-PLC-IP3R-Ca(2+) signaling cascade

Schiel, J.A.; Prekeris, R., 2011:
ESCRT or endosomes?: Tales of the separation of two daughter cells

Luzio, J.Paul.; Piper, Sân.C.; Bowers, K.; Parkinson, M.D.J.; Lehner, P.J.; Bright, N.A., 2009:
ESCRT proteins and the regulation of endocytic delivery to lysosomes

Woodman, P., 2009:
ESCRT proteins, endosome organization and mitogenic receptor down-regulation

Tu, C.; Ahmad, G.; Mohapatra, B.; Bhattacharyya, S.; Ortega-Cava, C.F.; Chung, B.Min.; Wagner, K-Uwe.; Raja, S.M.; Naramura, M.; Band, V.; Band, H., 2011:
ESCRT proteins: Double-edged regulators of cellular signaling

Kolb, A.R.; Needham, P.G.; Rothenberg, C.; Guerriero, C.J.; Welling, P.A.; Brodsky, J.L., 2014:
ESCRT regulates surface expression of the Kir2.1 potassium channel

Sandrin, V.; Sundquist, W.I., 2014:
ESCRT requirements for EIAV budding

Lee, J-A.; Gao, F-Biao., 2009:
ESCRT, autophagy, and frontotemporal dementia

Mayers, J.R.; Fyfe, I.; Schuh, A.L.; Chapman, E.R.; Edwardson, J.Michael.; Audhya, A., 2011:
ESCRT-0 assembles as a heterotetrameric complex on membranes and binds multiple ubiquitinylated cargoes simultaneously

Tognon, E.; Wollscheid, N.; Cortese, K.; Tacchetti, C.; Vaccari, T., 2015:
ESCRT-0 is not required for ectopic Notch activation and tumor suppression in Drosophila

Truschel, S.T.; Simoes, S.; Setty, S.Rao.Gangi.; Harper, D.C.; Tenza, Dèle.; Thomas, P.C.; Herman, K.E.; Sackett, S.D.; Cowan, D.C.; Theos, A.C.; Raposo, Gça.; Marks, M.S., 2010:
ESCRT-I function is required for Tyrp1 transport from early endosomes to the melanosome limiting membrane

Spallek, T.; Beck, M.; Ben Khaled, S.; Salomon, S.; Bourdais, G.; Schellmann, S.; Robatzek, S., 2014:
ESCRT-I mediates FLS2 endosomal sorting and plant immunity

Handschuh, K.; Feenstra, J.; Koss, M.; Ferretti, E.; Risolino, M.; Zewdu, R.; Sahai, M.A.; Bénazet, J-Denis.; Peng, X.P.; Depew, M.J.; Quintana, L.; Sharpe, J.; Wang, B.; Alcorn, H.; Rivi, R.; Butcher, S.; Manak, J.Robert.; Vaccari, T.; Weinstein, H.; Anderson, K.V.; Lacy, E.; Selleri, L., 2015:
ESCRT-II/Vps25 constrains digit number by endosome-mediated selective modulation of FGF-SHH signaling

Lafaurie-Janvore, J.; Maiuri, P.; Wang, Iène.; Pinot, M.; Manneville, J-Baptiste.; Betz, T.; Balland, M.; Piel, M., 2013:
ESCRT-III assembly and cytokinetic abscission are induced by tension release in the intercellular bridge

Hadders, M.A.; Agromayor, M.; Obita, T.; Perisic, O.; Caballe, A.; Kloc, M.; Lamers, M.H.; Williams, R.L.; Martin-Serrano, J., 2013:
ESCRT-III binding protein MITD1 is involved in cytokinesis and has an unanticipated PLD fold that binds membranes

Carlton, J.G.; Caballe, A.; Agromayor, M.; Kloc, M.; Martin-Serrano, J., 2012:
ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C

Härtel, T.; Schwille, P., 2014:
ESCRT-III mediated cell division in Sulfolobus acidocaldarius - a reconstitution perspective

Weiss, P.; Huppert, S.; Kölling, R., 2008:
ESCRT-III protein Snf7 mediates high-level expression of the SUC2 gene via the Rim101 pathway

Morita, E.; Sandrin, V.; McCullough, J.; Katsuyama, A.; Baci Hamilton, I.; Sundquist, W.I., 2011:
ESCRT-III protein requirements for HIV-1 budding

Balut, C.M.; Gao, Y.; Murray, S.A.; Thibodeau, P.H.; Devor, D.C., 2010:
ESCRT-dependent targeting of plasma membrane localized KCa3.1 to the lysosomes

Norgan, A.P.; Lee, J.R.E.; Oestreich, A.J.; Payne, J.A.; Krueger, E.W.; Katzmann, D.J., 2013:
ESCRT-independent budding of HIV-1 gag virus-like particles from Saccharomyces cerevisiae spheroplasts

Castro-Gomes, T.; Koushik, A.B.; Andrews, N.W., 2015:
ESCRT: nipping the wound in the bud?

Saksena, S.; Emr, S.D., 2009:
ESCRTs and human disease

Odorizzi, G., 2015:
ESCRTs take on a job in surveillance

Larsson, K.; de Wit, C.A.; Sellström, U.; Sahlström, L.; Lindh, C.H.; Berglund, M., 2018:
Brominated Flame Retardants and Organophosphate Esters in Preschool Dust and Children's Hand Wipes

Pereira, C.F.; Piccolo, F.M.; Tsubouchi, T.; Sauer, S.; Ryan, N.K.; Bruno, L.; Landeira, D.; Santos, J.; Banito, A.; Gil, J.; Koseki, H.; Merkenschlager, M.; Fisher, A.G., 2010:
ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency

Bok, G.Hyun.; Cho, J.Young., 2012:
ESD Hands-on Course Using Ex Vivo and In Vivo Models in South Korea

Kim, M-Young.; Cho, J-Hyung.; Jain, P.; Cho, J.Young., 2014:
ESD around the world: Asia

Neuhaus, H., 2014:
ESD around the world: Europe

Fukami, N., 2014:
ESD around the world: United States

Chandrasekhara, V.; Ginsberg, G.G., 2012:
ESD for colorectal neoplasms: dissecting value from virtue

Herreros de Tejada, A., 2014:
ESD training: A challenging path to excellence

Sadeghi, M.M.; Esmailzadeh, L.; Zhang, J.; Guo, X.; Asadi, A.; Krassilnikova, S.; Fassaei, H.R.; Luo, G.; Al-Lamki, R.S.M.; Takahashi, T.; Tellides, G.; Bender, J.R.; Rodriguez, E.R., 2007:
ESDN is a marker of vascular remodeling and regulator of cell proliferation in graft arteriosclerosis

Iwai, S.; Amekawa, S.; Yomogida, K.; Sumi, T.; Nakazawa, M.; Yura, Y.; Nishimune, Y.; Nozaki, M., 2008:
ESE-1 inhibits the invasion of oral squamous cell carcinoma in conjunction with MMP-9 suppression

Lee, S-Ho.; Bahn, J.Hoon.; Choi, C.Kyoung.; Whitlock, N.C.; English, A.E.; Safe, S.; Baek, S.Joon., 2009:
ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells

Albino, D.; Longoni, N.; Curti, L.; Mello-Grand, M.; Pinton, S.; Civenni, G.; Thalmann, G.; D'Ambrosio, G.; Sarti, M.; Sessa, F.; Chiorino, G.; Catapano, C.V.; Carbone, G.M., 2012:
ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features

Silva, K.Ishara.; Michael, B.C.; Geib, S.J.; Saxena, S., 2015:
ESEEM analysis of multi-histidine Cu(II)-coordination in model complexes, peptides, and amyloid-β

Dasgupta, J.; Tyryshkin, A.M.; Dismukes, G.Charles., 2007:
ESEEM spectroscopy reveals carbonate and an N-donor protein-ligand binding to Mn2+ in the photoassembly reaction of the Mn4Ca cluster in photosystem II

McCracken, J.; Vassiliev, I.R.; Yang, E-Che.; Range, K.; Barry, B.A., 2007:
ESEEM studies of peptide nitrogen hyperfine coupling in tyrosyl radicals and model peptides

Gatti, A.M.; Kirkpatrick, J.; Gambarelli, A.; Capitani, F.; Hansen, T.; Eloy, R.; Clermont, G., 2008:
ESEM evaluations of muscle/nanoparticles interface in a rat model

McGregor, J.E.; Donald, A.M., 2010:
ESEM imaging of dynamic biological processes: the closure of stomatal pores

Dracopoulos, V.; Danilatos, G., 2012:
ESEM modifications to LEO SUPRA 35 VP FESEM

Carrier, B.; Wang, L.; Vandamme, M.; Pellenq, R.J-M.; Bornert, M.; Tanguy, A.; Van Damme, H., 2013:
ESEM study of the humidity-induced swelling of clay film

Ip, K.Hong.; Stuart, B.; Ray, A.; Thomas, P., 2010:
ESEM-EDS investigation of the weathering of a heritage Sydney sandstone

Iordanidis, A.; Buckman, J.; Triantafyllou, A.G.; Asvesta, A., 2007:
ESEM-EDX characterisation of airborne particles from an industrialised area of northern Greece

Lawson, K.A.; Teteak, C.J.; Gao, J.; Li, N.; Hacquebord, J.; Ghatan, A.; Zielinska-Kwiatkowska, A.; Song, G.; Chansky, H.A.; Yang, L., 2014:
ESET histone methyltransferase regulates osteoblastic differentiation of mesenchymal stem cells during postnatal bone development

Hwang, Y.Jin.; Han, D.; Kim, K.Yoon.; Min, S-Joon.; Kowall, N.W.; Yang, L.; Lee, J.; Kim, Y.; Ryu, H., 2014:
ESET methylates UBF at K232/254 and regulates nucleolar heterochromatin plasticity and rDNA transcription

Gomez-Puertas, P.; Valencia, A., 2008:
ESF Programme on 'Integrated Approaches for Functional Genomics' Workshop on 'Modelling of Molecular Networks'

Wixon, J.; Marsh, J., 2008:
ESF Programme on Functional Genomics 1st European Conference: Functional Genomics and Disease 2003

Cesareni, G., 2008:
ESF Workshop 'Proteomics: Focus on Protein Interactions'

van der Vet, P.; Huibers, T.; Binz, P-Alain.; Hofmann, M., 2008:
ESF workshop on 'Sustainability and Governance of Web and GRID Resources in Functional Genomics'

Schäfer, B.W.; Koscielniak, E.; Kovar, H.; Fulda, S., 2013:
ESF-EMBO Symposium "Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence" Sept 29-Oct 4, Polonia Castle Pultusk, Poland

ter Brake, O.; Haasnoot, J.; Kurreck, J.; Berkhout, B., 2008:
ESF-EMBO symposium: antiviral applications of RNA interference

Dickson, D., 1983:
ESF: Modest Plans, Modest Achievements

Stegmayr, B., 2008:
ESFH congress held in Dusseldorf, Germany September 16-19, 2008

Stegmayr, B., 2008:
ESFH letter

Chitale, M.; Hawkins, T.; Park, C.; Kihara, D., 2009:
ESG: extended similarity group method for automated protein function prediction

Zacs, D.; Rjabova, J.; Ikkere, L.E.; Bavrins, K.; Bartkevics, V., 2017:
Brominated flame retardants and toxic elements in the meat and liver of red deer (Cervus elaphus), wild boar (Sus scrofa), and moose (Alces alces) from Latvian wildlife

Drage, D.S.; Sharkey, M.; Abdallah, M.Abou-Elwafa.; Berresheim, H.; Harrad, S., 2018:
Brominated flame retardants in Irish waste polymers: Concentrations, legislative compliance, and treatment options

Valenzuela-Sánchez, I.S.; Gold-Bouchot, G.; Hernández-Núñez, E.; Barrientos-Medina, R.C.; Garza-Gisholt, E.; Zapata-Pérez, O., 2018:
Brominated Flame Retardants in Sediments of Four Coastal Lagoons of Yucatan, Mexico

Čulin, J., 2018:
Brominated flame retardants: Recommendation for different listing under the Hong Kong Convention

Au, H.; Rubio, N.; Shaffer, M.S.P., 2018:
Brominated graphene as a versatile precursor for multifunctional grafting

Upmann, D.; Jones, P.G., 2018:
Bromination and iodination of diphosphane dichalcogenides

Reiss, H.; Ji, L.; Han, J.; Koser, S.; Tverskoy, O.; Freudenberg, J.; Hinkel, F.; Moos, M.; Friedrich, A.; Krummenacher, I.; Lambert, C.; Braunschweig, H.; Dreuw, A.; Marder, T.B.; Bunz, U.H.F., 2018:
Bromination Improves the Electron Mobility of Tetraazapentacene

Vergote, I.; van der Zee, A.G.J.; Kesic, V.; Sert, B.; Robova, H.; Rob, L.; Reed, N.; Luesley, D.M.; Leblanc, E.; Hagen, B.; Gitsch, G.; du Bois, A.; di Vagno, G.; Colombo, N.; Beller, U.; Ayhan, A.; Jacobs, I., 2007:
ESGO statement on cervical cancer vaccination

van der Zee, A.G.J.; Colombo, N.; Gitsch, G.; Reed, N.; Amant, F.; Cibula, D.; Kesic, V.I.; Kimmig, R.; Lopes, A.D.B.; Markowska, J.; Marth, C.; Radolakis, A.; Salvesen, H.; Vaitkiene, D.; Verheijen, Ré.H.M.; Zola, P., 2012:
ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer

Schmieder, R.E.; Redon, J.; Grassi, G.; Kjeldsen, S.E.; Mancia, G.; Narkiewicz, K.; Parati, G.; Ruilope, L.; van de Borne, P.; Tsioufis, C., 2012:
ESH position paper: renal denervation - an interventional therapy of resistant hypertension

Widimsky, J., 2007:
ESH update on hypertension management

Balducci, L., 2011:
ESH-SIOG International Conference on Haematological Malignancies in the Elderly

Mancia, G.; D.B.cker, G.; Dominiczak, A.; Cifkova, R.; Fagard, R.; Germano, G.; Grassi, G.; Heagerty, A.M.; Kjeldsen, S.E.; Laurent, S.; Narkiewicz, K.; Ruilope, L.; Rynkiewicz, A.; Schmieder, R.E.; Boudier, H.A.J.Struijker.; Zanchetti, A.; Vahanian, A.; Camm, J.; D.C.terina, R.; Dean, V.; Dickstein, K.; Filippatos, G.; Funck-Brentano, C.; Hellemans, I.; Kristensen, S.Dalby.; McGregor, K.; Sechtem, U.; Silber, S.; Tendera, M.; Widimsky, P.; Zamorano, Jé.Luis.; Erdine, S.; Kiowski, W.; Agabiti-R, 2007:
ESH/ESC 2007 Guidelines for the management of arterial hypertension

Halimi, J-Michel., 2013:
ESH/ESC and French guidelines for the management of hypertension: Similarities and discrepancies

Labrador, J.; Cabrero-Calvo, Mónica.; Pérez-López, Eía.; Mateos, Mía.Victoria.; Vázquez, L.; Caballero, Mía.Dolores.; García-Sanz, Rón., 2015:
ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma

Tempescul, A.; Ianotto, J.C.; Eveillard, J.R.; Guillerm, G.; Berthou, C., 2011:
ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation

Avilés, A.; Neri, N.; Huerta-Guzmán, J.; de Jesús Nambo, Mía., 2010:
ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma

Goossens, V.; Harton, G.; Moutou, C.; Traeger-Synodinos, J.; Van Rij, M.; Harper, J.C., 2009:
ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007

Goossens, V.; Harton, G.; Moutou, C.; Scriven, P.N.; Traeger-Synodinos, J.; Sermon, K.; Harper, J.C., 2008:
ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006

Harper, J.C.; Coonen, E.; De Rycke, M.; Harton, G.; Moutou, C.; Pehlivan, T.; Traeger-Synodinos, J.; Van Rij, M.C.; Goossens, V., 2011:
ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008

Goossens, V.; Traeger-Synodinos, J.; Coonen, E.; De Rycke, M.; Moutou, C.; Pehlivan, T.; Derks-Smeets, I.A.P.; Harton, G., 2012:
ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009

Moutou, C.; Goossens, V.; Coonen, E.; De Rycke, M.; Kokkali, G.; Renwick, P.; SenGupta, S.B.; Vesela, K.; Traeger-Synodinos, J., 2014:
ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010

Harton, G.L.; Magli, M.C.; Lundin, K.; Montag, M.; Lemmen, J.; Harper, J.C., 2011:
ESHRE PGD Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS)

Harton, G.L.; D.R.cke, M.; Fiorentino, F.; Moutou, C.; SenGupta, S.; Traeger-Synodinos, J.; Harper, J.C., 2011:
ESHRE PGD consortium best practice guidelines for amplification-based PGD

Harton, G.L.; Harper, J.C.; Coonen, E.; Pehlivan, T.; Vesela, K.; Wilton, L., 2011:
ESHRE PGD consortium best practice guidelines for fluorescence in situ hybridization-based PGD

Harton, G.; Braude, P.; Lashwood, A.; Schmutzler, A.; Traeger-Synodinos, J.; Wilton, L.; Harper, J.C., 2011:
ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening

Liu, J.; Chen, Q.; He, Q.; Zhang, Y.; Fu, X.; Wang, Y.; Zhao, D.; Chen, W.; Xu, G.Qin.; Wu, K., 2018:
Bromine adatom promoted C-H bond activation in terminal alkynes at room temperature on Ag(111)

Lv, Y.; Shi, Y.; Song, X.; Liu, J.; Wang, M.; Wang, S.; Feng, Y.; Jin, S.; Hao, C., 2018:
Bromine Doping as an Efficient Strategy to Reduce the Interfacial Defects in Hybrid Two-Dimensional/Three-Dimensional Stacking Perovskite Solar Cells

Adonin, S.A.; Gorokh, I.D.; Novikov, A.S.; Samsonenko, D.G.; Plyusnin, P.E.; Sokolov, M.N.; Fedin, V.P., 2018:
Bromine-rich complexes of bismuth: experimental and theoretical studies

Ferraretti, A.P.; La Marca, A.; Fauser, B.C.J.M.; Tarlatzis, B.; Nargund, G.; Gianaroli, L., 2011:
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

Dunselman, G.A.J.; Vermeulen, N.; Becker, C.; Calhaz-Jorge, C.; D'Hooghe, T.; De Bie, B.; Heikinheimo, O.; Horne, A.W.; Kiesel, L.; Nap, A.; Prentice, A.; Saridogan, E.; Soriano, D.; Nelen, W., 2014:
ESHRE guideline: management of women with endometriosis

Anonymous, 2018 :

Adonin, S.A.; Bondarenko, M.A.; Abramov, P.A.; Novikov, A.S.; Plyusnin, P.E.; Sokolov, M.N.; Fedin, V.P., 2018:
Bromo- and Polybromoantimonates(V): Structural and Theoretical Studies of Hybrid Halogen-Rich Halometalate Frameworks

Shenfield, F.; Pennings, G.; De Mouzon, J.; Ferraretti, A.P.; Goossens, V., 2011:
ESHRE's good practice guide for cross-border reproductive care for centers and practitioners

Motti, C.A.; Ettinger-Epstein, P.; Willis, R.H.; Tapiolas, D.M., 2010:
ESI FTICR-MS analysis of larvae from the marine sponge Luffariella variabilis

Medana, C.; Calza, P.; Deagostino, A.; Dal Bello, F.; Raso, E.; Baiocchi, C., 2011:
ESI HRMS(n) fragmentation pathways of phenazone, an N-heterocyclic drug compound

Li, X-Yu.; Mao, Z-Chao.; Wang, Y-Hu.; Wu, Y-Xing.; He, Y-Qiu.; Long, C-Lin., 2012:
ESI LC-MS and MS/MS characterization of antifungal cyclic lipopeptides produced by Bacillus subtilis XF-1

Fan, J.; Upadhye, S.; Woolfrey, K., 2007:

Hubert, Cécile.; Dossmann, Héloïse.; Machuron-Mandard, X.; Tabet, J-Claude., 2013:
ESI formation of a Meisenheimer complex from tetryl and its unusual dissociation

Zhou, D-Wei.; Xu, Y-Li.; Wu, J-Li., 2013:
ESI fragmentation studies of six unusual nucleotide sugars

Tittebrandt, S.; Edelson-Averbukh, M.; Spengler, B.; Lehmann, W.D., 2014:
ESI hydrogen/deuterium exchange can count chemical forms of heteroatom-bound hydrogen

Cui, X.; Zhang, Q.; Chen, H.; Zhou, J.; Yuan, G., 2014:
ESI mass spectrometric exploration of selective recognition of G-quadruplex in c-myb oncogene promoter using a novel flexible cyclic polyamide

Pereira, F.S.; Nascimento, H.D.L.; Magalhães, Aér.; Peter, M.G.; Bataglion, G.Anceski.; Eberlin, M.N.; González, E.R.P., 2015:
ESI(+)-MS and GC-MS study of the hydrolysis of N-azobenzyl derivatives of chitosan

Lehner, A.F.; Petzinger, E.; Stewart, J.; Lang, D.G.; Johnson, M.B.; Harrison, L.; Seanor, J.W.; Tobin, T., 2008:
ESI+ MS/MS confirmation of canine ivermectin toxicity

Dolashka, P.; Zal, F.; Dolashki, A.; Molin, L.; Traldi, P.; Salvato, B., 2012:
ESI-MS and MALLS analysis of quaternary structure of molluscan hemocyanins

Bartók, T.; Szécsi, Á.; Juhász, K.; Bartók, M.; Mesterházy, Á., 2014:
ESI-MS and MS/MS identification of the first ceramide analogues of fumonisin B₁ mycotoxin from a Fusarium verticillioides culture following RP-HPLC separation

Schilter, D.; Urathamakul, T.; Beck, J.L.; Harding, M.M.; Rendina, L.M., 2011:
ESI-MS and thermal melting studies of nanoscale platinum(II) metallomacrocycles with DNA

Barry, C.S.; Backus, K.M.; Barry, C.E.; Davis, B.G., 2011:
ESI-MS assay of M. tuberculosis cell wall antigen 85 enzymes permits substrate profiling and design of a mechanism-based inhibitor

Pierce, S.E.; Sherman, C.L.; Jayawickramarajah, J.; Lawrence, C.M.; Sessler, J.L.; Brodbelt, J.S., 2008:
ESI-MS characterization of a novel pyrrole-inosine nucleoside that interacts with guanine bases

Frański, Rł.; Gierczyk, Błazej., 2010:
ESI-MS detection of very weak pi-stacking interactions in the mixed-ligand sandwich complexes formed by substituted benzo-crown ethers and metal cations

Gonçalves, A.G.; Ducatti, D.R.B.; Grindley, T.Bruce.; Duarte, M.Eugênia.R.; Noseda, M.D., 2010:
ESI-MS differential fragmentation of positional isomers of sulfated oligosaccharides derived from carrageenans and agarans

Wijeratne, A.B.; Yang, S.H.; Gracia, J.; Armstrong, D.W.; Schug, K.A., 2011:
ESI-MS investigation of solvent effects on the chiral recognition capacity of tartar emetic towards neutral side-chain amino acids

Kobetić, R.; Gembarovski, D.; Visnjevac, A.; Zinić, B.; Gabelica-Marković, V., 2010:
ESI-MS studies of palladium (II) complexes with 1-(p-toluenesulfonyl)cytosine/cytosinato ligands

Novikov, A.V.; Bublyaev, R.A.; Krasnov, N.V.; Kozmin, Y.P.; Mirgorodskaya, O.A., 2011:
ESI-MS studies of silver ion competitive interaction with cysteine-containing peptides and sulfur-containing amino aсids

Vasseur, A.; Harakat, D.; Muzart, J.; Le Bras, J., 2012:
ESI-MS studies of the dehydrogenative Heck reaction of furans with acrylates using benzoquinone as the reoxidant and DMSO as the solvent

Zhao, Z-Xiong.; Wang, H-Yang.; Guo, Y-Long., 2011:
ESI-MS study on transient intermediates in the fast cyclopropenium-activated chlorination reaction of alcohols

Williams, V.M.; Kong, J.Rock.; Ko, B.Joon.; Mantri, Y.; Brodbelt, J.S.; Baik, M-Hyun.; Krische, M.J., 2010:
ESI-MS, DFT, and synthetic studies on the H(2)-mediated coupling of acetylene: insertion of C=X bonds into rhodacyclopentadienes and Brønsted acid cocatalyzed hydrogenolysis of organorhodium intermediates

Maldini, M.; Montoro, P.; Piacente, S.; Pizza, C., 2010:
ESI-MS, ESI-MS/MS fingerprint and LC-ESI-MS analysis of proathocyanidins from Bursera simaruba Sarg bark

Dresen, S.; Gergov, M.; Politi, L.; Halter, C.; Weinmann, W., 2010:
ESI-MS/MS library of 1,253 compounds for application in forensic and clinical toxicology

Primassin, S.; Spiekerkoetter, U., 2011:
ESI-MS/MS measurement of free carnitine and its precursor γ-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders

DeBarber, A.E.; Connor, W.E.; Pappu, A.S.; Merkens, L.S.; Steiner, R.D., 2010:
ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis

Khuroo, A.H.; Gurule, S.J.; Monif, T.; Goswami, D.; Saha, A.; Singh, S.K., 2012:
ESI-MS/MS stability-indicating bioanalytical method development and validation for simultaneous estimation of donepezil, 5-desmethyl donepezil and 6-desmethyl donepezil in human plasma

Lehner, A.F.; Duringer, J.M.; Estill, C.T.; Tobin, T.; Craig, A.Morrie., 2012:
ESI-Mass spectrometric and HPLC elucidation of a new ergot alkaloid from perennial ryegrass hay silage associated with bovine reproductive problems

Sanyal, D.; Ghosh, S., 2013:
ESICON 2012, Kolkata: The best of Indian Endocrinology

Anastyuk, S.D.; Imbs, T.I.; Shevchenko, N.M.; Dmitrenok, P.S.; Zvyagintseva, T.N., 2013:
ESIMS analysis of fucoidan preparations from Costaria costata, extracted from alga at different life-stages

Wang, S-Min.; Zhu, W-Guo.; Kang, J-Xun.; Liu, H-Min.; Chen, J-Miao.; Li, C-Ping.; Zhang, K., 2011:
ESIMS and NMR studies on the selective deprotection of acetylated glucosides by dibutyltin oxide

Wang, H-Yang.; Yim, W-Leung.; Klüner, T.; Metzger, Jürgen.O., 2009:
ESIMS studies and calculations on alkali-metal adduct ions of ruthenium olefin metathesis catalysts and their catalytic activity in metathesis reactions

Chevalier, K.; Grün, A.; Stamm, A.; Schmitt, Y.; Gerhards, M.; Diller, R., 2013:
ESIPT and photodissociation of 3-hydroxychromone in solution: photoinduced processes studied by static and time-resolved UV/Vis, fluorescence, and IR spectroscopy

Latha, V.; Annaraj, B.; Neelakantan, M.A., 2015:
ESIPT inspired dual fluorescent probe (Z)-3-((4-(4-aminobenzyl) phenyl) amino)-1,3-diphenylprop-2-en-1-one: experimental and DFT based approach to photophysical properties

Xia, B.; Gerard, B.; Solano, D.M.; Wan, J.; Jones, G.; Porco, J.A., 2011:
ESIPT-mediated photocycloadditions of 3-hydroxyquinolinones: development of a fluorescence quenching assay for reaction screening

Winkler, R., 2010:
ESIprot: a universal tool for charge state determination and molecular weight calculation of proteins from electrospray ionization mass spectrometry data

Koenig, T.; Bauersachs, J.; Hilfiker-Kleiner, D., 2018:
Bromocriptine for the Treatment of Peripartum Cardiomyopathy

Ersbøll, A.Schjødt.; Arany, Z.; Gustafsson, F., 2018:
Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a Danish cohort

Lefebvre, Vérie.; Fortabat, M-Noëlle.; Ducamp, Aïse.; North, H.M.; Maia-Grondard, A.; Trouverie, J.; Boursiac, Y.; Mouille, G.; Durand-Tardif, Mène., 2013:
ESKIMO1 disruption in Arabidopsis alters vascular tissue and impairs water transport

Callahan, R.; Wilkinson, L.; Muller, C.; Frisco, M., 2009:
ESL Placement and Schools: Effects on Immigrant Achievement

Santos, M.G.; Handley, M.A.; Omark, K.; Schillinger, D., 2015:
ESL participation as a mechanism for advancing health literacy in immigrant communities

Nimmon, L.E., 2007:
ESL-speaking immigrant women's disillusions: voices of health care in Canada: an ethnodrama

Poirier, G.M.; Bergmann, C.; Denais-Lalieve, D.G.; Dontas, I.A.; Dudoignon, N.; Ehall, H.; Fentener van Vlissingen, J.M.; Fornasier, M.; Kalman, R.; Hansen, A.; Schueller, S.; Vergara, P.; Weilenmann, R.; Wilson, J.; Degryse, A-D., 2015:
ESLAV/ECLAM/LAVA/EVERI recommendations for the roles, responsibilities and training of the laboratory animal veterinarian and the designated veterinarian under Directive 2010/63/EU

Garg, A.; Raghava, G.P.S., 2008:
ESLpred2: improved method for predicting subcellular localization of eukaryotic proteins

Ziol, M.; Sutton, A.; Calderaro, J.; Barget, N.; Aout, M.; Leroy, V.; Blanc, J-Frédéric.; Sturm, N.; Bioulac-Sage, P.; Nahon, P.; Nault, J-Charles.; Charnaux, N.; N'kontchou, Gèle.; Trinchet, J-Claude.; Delehedde, M.; Seror, O.; Beaugrand, M.; Vicaut, E.; Ganne-Carrié, N., 2014:
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma

Kang, Y.Hee.; Ji, N.Young.; Lee, C.Il.; Lee, H.Gu.; Kim, J.Wha.; Yeom, Y.Il.; Kim, D.Ghon.; Yoon, S.Kew.; Kim, J.Wan.; Park, P.Je.; Song, E.Young., 2011:
ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma

Ciecierska, H.; Kolada, A., 2014:
ESMI: a macrophyte index for assessing the ecological status of lakes

Cherny, N.I.; Cervantes, Aés.; Pentheroudakis, G.; Felip, E.; Pavlidis, N.; Stahel, R.A.; Cardoso, F.; Senkus-Konefka, E.; Arnold, D.; Rougier, P.; Horwich, A.; Sessa, C.; Colombo, N.; Licitra, L.; Buske, C.; Ladetto, M.; Peters, S.; Casali, P.; Keilholz, U.; Cherny, N.; Herrstedt, Jørn., 2015:
ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation

Schrijvers, D.; Cherny, N.I.; Cervantes, Aés.; Pentheroudakis, G.; Felip, E.; Pavlidis, N.; Stahel, R.A.; Cardoso, F.; Senkus-Konefka, E.; Arnold, D.; Rougier, P.; Horwich, A.; Sessa, C.; Colombo, N.; Licitra, L.; Buske, C.; Ladetto, M.; Peters, S.; Casali, P.; Keilholz, U.; Cherny, N.; Herrstedt, Jørn., 2015:
ESMO Clinical Practice Guidelines on palliative care: advanced care planning

Pavlidis, N.; Hansen, H.; Stahel, R., 2010:
ESMO Clinical Practice Guidelines: development, implementation and dissemination

Raskin, P.; Cincotta, A.H., 2016:
Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary

Pavlidis, N.; Stahel, R.; Pentheroudakis, G.; Cervantes, A., 2013:
ESMO Consensus Conferences: another source of ESMO Clinical Practice Guidelines

Schmoll, H.J.; Van Cutsem, E.; Stein, A.; Valentini, V.; Glimelius, B.; Haustermans, K.; Nordlinger, B.; van de Velde, C.J.; Balmana, J.; Regula, J.; Nagtegaal, I.D.; Beets-Tan, R.G.; Arnold, D.; Ciardiello, F.; Hoff, P.; Kerr, D.; Köhne, C.H.; Labianca, R.; Price, T.; Scheithauer, W.; Sobrero, A.; Tabernero, J.; Aderka, D.; Barroso, S.; Bodoky, G.; Douillard, J.Y.; El Ghazaly, H.; Gallardo, J.; Garin, A.; Glynne-Jones, R.; Jordan, K.; Meshcheryakov, A.; Papamichail, D.; Pfeiffer, P.; Souglakos, 2013:
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making

Dreyling, M.; Thieblemont, C.; Gallamini, A.; Arcaini, L.; Campo, E.; Hermine, O.; Kluin-Nelemans, J.C.; Ladetto, M.; Le Gouill, S.; Iannitto, E.; Pileri, S.; Rodriguez, J.; Schmitz, N.; Wotherspoon, A.; Zinzani, P.; Zucca, E., 2013:
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

Ghielmini, M.; Vitolo, U.; Kimby, E.; Montoto, S.; Walewski, J.; Pfreundschuh, M.; Federico, M.; Hoskin, P.; McNamara, C.; Caligaris-Cappio, F.; Stilgenbauer, S.; Marcus, R.; Trneny, M.; Dreger, P.; Montserrat, E.; Dreyling, M.; Agostinelli, C.; Arcaini, L.; Caligaris-Cappio, F.; Campo, E.; Coiffier, B.; Corradini, P.; D'Amore, F.; Dreger, P.; Dreyling, M.; Federico, M.; Gallamini, A.; Gaulard, P.; Geisler, C.H.; Ghielmini, M.; Gisselbrecht, C.; da Silva, M.Gomes.; Gribben, J.; Hermine, O.;, 2013:
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

Anonymous, 2014:
ESMO Symposium on Immuno-Oncology 2014 Organisation

Pavlidis, N.; Hansen, H.; Stahel, R., 2007:
ESMO clinical recommendations: a practical guide for medical oncologists

Pavlidis, N.; Hansen, H.; Stahel, R., 2010:
ESMO clinical recommendations: using the easier and faster approach to oncology guidelines

Anonymous, 2013:
ESMO: regorafenib improved PFS for GIST in post-imatinib/sunitinib setting

Sarmah, R.; Sahu, J.; Dehury, B.; Sarma, K.; Sahoo, S.; Sahu, M.; Barooah, M.; Sen, P.; Modi, M.Kumar., 2012:
ESMP: A high-throughput computational pipeline for mining SSR markers from ESTs

Rovida, C.; Vivier, M.; Garthoff, B.; Hescheler, Jürgen., 2014:
ESNATS conference - the use of human embryonic stem cells for novel toxicity testing approaches

Zhou, X.; Han, P.; Li, J.; Zhang, X.; Huang, B.; Ruan, H-Qiang.; Chen, C., 2011:
ESNOQ, proteomic quantification of endogenous S-nitrosation

Haghikia, A.; Schwab, J.; Vogel-Claussen, J.; Berliner, D.; Pfeffer, T.; König, T.; Zwadlo, C.; Moulig, V.Abou.; Franke, A.; Schwarzkopf, M.; Ehlermann, P.; Pfister, R.; Michels, G.; Westenfeld, R.; Stangl, V.; Kühl, U.; Podewski, E.; Kindermann, I.; Böhm, M.; Sliwa, K.; Hilfiker-Kleiner, D.; Bauersachs, J., 2018:
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction

Estensoro, I.; Pérez-Cordón, G.; Sitjà-Bobadilla, A.; Piazzon, M.C., 2017:
Bromodeoxyuridine DNA labelling reveals host and parasite proliferation in a fish-myxozoan model

Clery, D., 1995:
ESO and Chile Begin to Clear the Air

Cardoso, F.; Costa, A.; Norton, L.; Senkus, E.; Aapro, M.; André, F.; Barrios, C.H.; Bergh, J.; Biganzoli, L.; Blackwell, K.L.; Cardoso, M.J.; Cufer, T.; El Saghir, N.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K.; Giordano, S.H.; Gligorov, J.; Goldhirsch, A.; Harbeck, N.; Houssami, N.; Hudis, C.; Kaufman, B.; Krop, I.; Kyriakides, S.; Lin, U.N.; Mayer, M.; Merjaver, S.D.; Nordström, E.B.; Pagani, O.; Partridge, A.; Penault-Llorca, F.; Piccart, M.J.; Rugo, H.; Sledge, G.; Thomssen, C.;, 2015:
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

Stewart, S., 2012:
ESOL for health: helping those with limited English language skills to use the NHS

Rudman, M.D.; Choi, J.S.; Lee, H.Eun.; Tan, S.Kiat.; Ayad, N.G.; Lee, J.K., 2018:
Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury

Tart, C.T., 1978:
ESP Research

Diaconis, P., 1978:
ESP Research

Yoshinaga, S.; Haga, S.; Touhara, K.; Terasawa, H., 2011:
ESP family peptides and vomeronasal receptors in rodents

Bevan, J.M., 2011:
ESP tests in light and darkness

Ma, C.Je.; Kim, S.Hyun.; Lee, K.Yong.; Oh, T.; Kim, S.Yeou.; Sung, S.Hyun.; Kim, Y.Choong., 2010:
ESP-102, a combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, protects against glutamate-induced toxicity in primary cultures of rat cortical cells

Batista-Navarro, R.Theresa.B.; Bandojo, D.A.; Gatapia, M.A.Jaymee.Krisette.; Santos, R.Nicolo.C.; Marcelo, A.B.; Panganiban, L.Crisanta.R.; Naval, P.C., 2010:
ESP: an expert system for poisoning diagnosis and management

Campos, R.N.; Angst, J.; Cordas, T.A.; Moreno, R.A., 2011:
ESPECTRA: searching the bipolar spectrum in eating disorder patients

Singer, P.; Leon-Sanz, M.; Van Gossum, A., 2011:
ESPEN 2011: the present and the future

Cano, N.J.M.; Aparicio, M.; Brunori, G.; Carrero, J.J.; Cianciaruso, B.; Fiaccadori, E.; Lindholm, B.; Teplan, V.; Fouque, D.; Guarnieri, G., 2009:
ESPEN Guidelines on Parenteral Nutrition: adult renal failure

Pittiruti, M.; Hamilton, H.; Biffi, R.; MacFie, J.; Pertkiewicz, M., 2009:
ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications)

Van Gossum, Aé.; Cabre, E.; Hébuterne, X.; Jeppesen, P.; Krznaric, Z.; Messing, B.; Powell-Tuck, J.; Staun, M.; Nightingale, J., 2009:
ESPEN Guidelines on Parenteral Nutrition: gastroenterology

Sobotka, L.; Schneider, S.M.; Berner, Y.N.; Cederholm, T.; Krznaric, Z.; Shenkin, A.; Stanga, Z.; Toigo, G.; Vandewoude, M.; Volkert, D., 2009:
ESPEN Guidelines on Parenteral Nutrition: geriatrics

Plauth, M.; Cabré, E.; Campillo, B.; Kondrup, J.; Marchesini, G.; Schütz, T.; Shenkin, A.; Wendon, J., 2009:
ESPEN Guidelines on Parenteral Nutrition: hepatology

Staun, M.; Pironi, L.; Bozzetti, F.; Baxter, J.; Forbes, A.; Joly, F.; Jeppesen, P.; Moreno, J.; Hébuterne, X.; Pertkiewicz, M.; Mühlebach, S.; Shenkin, A.; Van Gossum, Aé., 2009:
ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients

Singer, P.; Berger, M.M.; Van den Berghe, G.; Biolo, G.; Calder, P.; Forbes, A.; Griffiths, R.; Kreyman, G.; Leverve, X.; Pichard, C.; ESPEN, 2009:
ESPEN Guidelines on Parenteral Nutrition: intensive care

Bozzetti, F.; Arends, J.; Lundholm, K.; Micklewright, A.; Zurcher, G.; Muscaritoli, M., 2009:
ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology

Anker, S.D.; Laviano, A.; Filippatos, G.; John, M.; Paccagnella, A.; Ponikowski, P.; Schols, A.M.W.J., 2009:
ESPEN Guidelines on Parenteral Nutrition: on cardiology and pneumology

Gianotti, L.; Meier, R.; Lobo, D.N.; Bassi, C.; Dejong, C.H.C.; Ockenga, J.; Irtun, O.; MacFie, J., 2009:
ESPEN Guidelines on Parenteral Nutrition: pancreas

Braga, M.; Ljungqvist, O.; Soeters, P.; Fearon, K.; Weimann, A.; Bozzetti, F., 2009:
ESPEN Guidelines on Parenteral Nutrition: surgery

Preiser, J-Charles.; Schneider, Séphane.M., 2012:
ESPEN disease-specific guideline framework

Pironi, L.; Arends, J.; Baxter, J.; Bozzetti, F.; Peláez, R.Burgos.; Cuerda, C.; Forbes, A.; Gabe, S.; Gillanders, L.; Holst, M.; Jeppesen, P.Bekker.; Joly, F.; Kelly, D.; Klek, S.; Irtun, Øivind.; Olde Damink, S.W.; Panisic, M.; Rasmussen, H.Højgaard.; Staun, M.; Szczepanek, K.; Van Gossum, Aé.; Wanten, G.; Schneider, Séphane.Michel.; Shaffer, J., 2015:
ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults

Andus, T., 2007:
ESPEN guidelines on enteral nutrition: liver disease - tube feeding (TF) in patients with esophageal varices is not proven to be safe

Koletzko, B.; Milla, P.John., 2016 :
ESPGHAN Distinguished Service Award 2014 to Professor Peter John Milla, MSc, MBBS

Egner, W.; Shrimpton, A.; Sargur, R.; Patel, D.; Swallow, K., 2013:
ESPGHAN guidance on coeliac disease 2012: multiples of ULN for decision making do not harmonise assay performance across centres

Heuschkel, R.B.; Gottrand, F.; Devarajan, K.; Poole, H.; Callan, J.; Dias, J.A.; Karkelis, S.; Papadopoulou, A.; Husby, S.; Ruemmele, F.; Schäppi, M.G.; Wilschanski, M.; Lionetti, P.; Orel, R.; Tovar, J.; Thapar, N.; Vandenplas, Y., 2015:
ESPGHAN position paper on management of percutaneous endoscopic gastrostomy in children and adolescents

Phillips, A.; Kelly, D.; Troncone, R.; Walker-Smith, J.Angus., 2011:
ESPGHAN presents first Distinguished Service Award at AGM 2010

Cattaneo, A.; Williams, C.; Pallás-Alonso, C.Rosa.; Hernández-Aguilar, M.Teresa.; Lasarte-Velillas, J.José.; Landa-Rivera, L.; Rouw, E.; Pina, Mónica.; Volta, A.; Oudesluys-Murphy, A.Marie., 2012:
ESPGHAN's 2008 recommendation for early introduction of complementary foods: how good is the evidence?

Finetti, P.; Guille, A.; Adelaide, Jé.; Birnbaum, D.; Chaffanet, M.; Bertucci, Fçois., 2015:
ESPL1 is a candidate oncogene of luminal B breast cancers

Syrmos, N.Ch.; Conde, M.García.; Akyva, Y., 2014:
ESPN Course 2013—the trainee's point of view

Combe, B., 2014:
ESPOIR and the French database management: what have we learned from the first years of follow-up?

van Leeuwen, K., 2007:
ESPR Subject Area 4 'Environmental Education, Science Communication, Science & Policy, Health Issues'

Offiah, A.C.; Adamsbaum, C.; van Rijn, R.R., 2015:
ESPR adopts British guidelines for imaging in suspected non-accidental injury as the European standard

Mensah, A.A.; Cascione, L.; Gaudio, E.; Tarantelli, C.; Bomben, R.; Bernasconi, E.; Zito, D.; Lampis, A.; Hahne, J.C.; Rinaldi, A.; Stathis, A.; Zucca, E.; Kwee, I.; Gattei, V.; Valeri, N.; Riveiro, M.E.; Bertoni, F., 2018:
Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma

Russell, J.O.; Ko, S.; Saggi, H.S.; Singh, S.; Poddar, M.; Shin, D.; Monga, S.P., 2018:
Bromodomain and Extraterminal (BET) Proteins Regulate Hepatocyte Proliferation in Hepatocyte-Driven Liver Regeneration

Wang, Y.; Wang, W.; Sun, H., 2018:
Bromodomain‑containing protein 4 is critical for the antiproliferative and pro‑apoptotic effects of gambogic acid in anaplastic thyroid cancer

Yan, A.; Yue, T.; Li, L.; Li, W.; Li, Q.; Li, J., 2017:
Bromodomain-containing protein 7 deficiency augments atherosclerotic lesions in ApoE -/- mice

Garrigues, P., 2013:
ESPR: a new dimension for its 20th anniversary!!

Hirose, S.; Noguchi, T., 2013:
ESPRESSO: a system for estimating protein expression and solubility in protein expression systems

Valero, A.; Izquierdo, I.; Sastre, J.; Navarro, A.M.; Baró, E.; Martí-Guadaño, E.; Ferrer, M.; Dávila, I.; del Cuvillo, A.; Colás, C.; Antépara, I.; Alonso, J.; Mullol, J., 2013:
ESPRINT-15 questionnaire (Spanish version): reference values according to disease severity using both the original and the modified ARIA classifications

Yumerefendi, H.; Tarendeau, F.; Mas, P.J.; Hart, D.J., 2011:
ESPRIT: an automated, library-based method for mapping and soluble expression of protein domains from challenging targets

Sun, Y.; Cai, Y.; Liu, L.; Yu, F.; Farrell, M.L.; McKendree, W.; Farmerie, W., 2009:
ESPRIT: estimating species richness using large collections of 16S rRNA pyrosequences

Rouhl, R.P.W.; Lodder, J., 2008:
ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?

Hecker, M.; Steinberg, C.; Young, A.L., 2007:
ESPR´s Total Environment

Frank, D.; Mouriquand, P., 2008:
ESPU/AAP meeting

Shoucri, R.M., 2011:
ESPVR, ejection fraction and heart failure

Shin, C.S.; Dunnam, C.R.; Borbat, P.P.; Dzikovski, B.; Barth, E.D.; Halpern, H.J.; Freed, J.H., 2011:
ESR Microscopy for Biological and Biomedical Applications

Rokhina, E.V.; Golovina, E.A.; As, H.van.; Virkutyte, J., 2009:
ESR ST study of hydroxyl radical generation in wet peroxide system catalyzed by heterogeneous ruthenium

Nestel, A.R., 2012:
ESR adaptation for age--a forgotten pearl

Debouzy, J-Claude.; Crouzier, D.; Favier, A-Laure.; Perino, J., 2011:
ESR and NMR studies provide evidence that phosphatidyl glycerol specifically interacts with poxvirus membranes

Paksu, U.; Aydaş, C.; Yüce, Ülkü.Rabia.; Aydın, T.; Polat, M.; Engin, B., 2013:
ESR and TL investigations on gamma irradiated linden (Tilia vulgaris)

Piccinato, M.Turini.; da Costa, M.Ferreira.; Ota, Aé.Tsutomu.; Guedes, C.Luísa.Barbosa.; Di Mauro, E., 2014:
ESR and calculations on electronic structure of phenalenyl and phenalenyl derivative radicals

Folch-Cano, C.; Olea-Azar, C.; Arán, V.J.; Diaz-Urrutia, C., 2010:
ESR and electrochemical study of 1,2-disubstituted 5-nitroindazolin-3-ones and 2-substituted 3-alkoxy-5-nitro-2H-indazoles: reactivity and free radical production capacity in the presence of biological systems

Kripal, R.; Yadav, M.P.; Shukla, S., 2011:
ESR and optical studies of Cu2+ doped zinc glutamate dihydrate

Kripal, R.; Singh, D.K., 2007:
ESR and optical study of Mn2+-doped sodium hydrogen orthophosphate dihydrate

Bogdanov, A.V.; Vorobiev, A.Kh., 2013:
ESR and optical study of photo-orientation in azobenzene-containing liquid-crystalline polymer

Sambasivam, S.; Sathyaseelan, B.; Raja Reddy, D.; Reddy, B.K.; Jayasankar, C.K., 2008:
ESR and photoluminescence properties of Cu doped ZnS nanoparticles

Helliwell, T.; Muller, S.; Hider, S., 2012:
ESR can be normal in giant cell arteritis and polymyalgia rheumatica

Anonymous, 2013:
ESR communication guidelines for radiologists

Toyoda, S.; Fujiwara, T.; Uchida, A.; Ishibashi, J-ichiro.; Nakai, S'ichi.; Takamasa, A., 2015:
ESR dating of barite in sulphide deposits formed by the sea-floor hydrothermal activities

Küçükuysal, C.; Engin, B.; Türkmenoğlu, A.G.; Aydaş, C., 2010:
ESR dating of calcrete nodules from Bala, Ankara (Turkey): preliminary results

Limsuwan, S.; Vichaidid, T.; Limsuwan, P., 2010:
ESR dating of laterite from Ban Tha Ta Suea, Kanchanaburi, Thailand

Liu, C-Ru.; Yin, G-Ming.; Deng, C-Long.; Han, F.; Song, W-Juan., 2015:
ESR dating of the Majuangou and Banshan Paleolithic sites in the Nihewan Basin, North China

Blackwell, B.A.B.; Gong, J.J.J.; Skinner, A.R.; Blais-Stevens, Aée.; Nelson, R.E.; Blickstein, J.I.B., 2010:
ESR dating pleistocene barnacles from BC and Maine: a new method for tracking sea level change

Sawada, T.; Yoshino, F.; Kimoto, K.; Takahashi, Y.; Shibata, T.; Hamada, N.; Sawada, T.; Toyoda, M.; Lee, M-C., 2010:
ESR detection of ROS generated by TiO2 coated with fluoridated apatite

Duval, M.; Guilarte Moreno, V.; Grün, R., 2014:
ESR dosimetry of fossil enamel: some comments about measurement precision, long-term signal fading and dose-response curve fitting